{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 473087, "items": [{"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T04:11:19Z", "timestamp": 1574136679080}, "reference-count": 0, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "5689", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science"], "published-print": {"date-parts": [[2004, 9, 3]]}, "DOI": "10.1126/science.1102974", "type": "journal-article", "created": {"date-parts": [[2004, 9, 2]], "date-time": "2004-09-02T21:23:05Z", "timestamp": 1094160185000}, "page": "1411-1413", "source": "Crossref", "is-referenced-by-count": 56, "title": ["MEDICINE: Targeting Apoptotic Pathways in Cancer Cells"], "prefix": "10.1126", "volume": "305", "author": [{"given": "C.", "family": "Denicourt", "sequence": "first", "affiliation": []}], "member": "221", "container-title": ["Science"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/science.1102974", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:06:44Z", "timestamp": 1482466004000}, "score": 58.809853, "issued": {"date-parts": [[2004, 9, 3]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2004, 9, 3]]}, "issue": "5689"}, "URL": "http://dx.doi.org/10.1126/science.1102974", "ISSN": ["0036-8075", "1095-9203"], "issn-type": [{"value": "0036-8075", "type": "print"}, {"value": "1095-9203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T06:31:28Z", "timestamp": 1574317888891}, "publisher-location": "Totowa, NJ", "reference-count": 195, "publisher": "Humana Press", "isbn-type": [{"value": "9781603275521", "type": "print"}, {"value": "9781603275538", "type": "electronic"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "published-print": {"date-parts": [[2009]]}, "DOI": "10.1007/978-1-60327-553-8_41", "type": "book-chapter", "created": {"date-parts": [[2009, 8, 15]], "date-time": "2009-08-15T04:05:22Z", "timestamp": 1250309122000}, "page": "977-1009", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Targeting of TRAIL Apoptotic Pathways for Glioblastoma Therapies"], "prefix": "10.1007", "author": [{"given": "Anita C.", "family": "Bellail", "sequence": "first", "affiliation": []}, {"given": "Patrick", "family": "Mulligan", "sequence": "additional", "affiliation": []}, {"given": "Chunhai", "family": "Hao", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2009, 5, 20]]}, "reference": [{"key": "41_CR1", "doi-asserted-by": "publisher", "first-page": "751", "DOI": "10.1038/sj.cdd.4402306", "volume": "15", "author": "C. Adams", "year": "2008", "unstructured": "Adams, C., Totpal, K., Lawrence, D., Marsters, S., Pitti, R., Yee, S., Ross, S., Deforge, L., Koeppen, H., Sagolla, M., et al. (2008). Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5. Cell Death Differ 15, 751\u2013761.", "journal-title": "Cell Death Differ"}, {"key": "41_CR2", "first-page": "533", "volume": "223", "author": "D. C. Altieri", "year": "2003", "unstructured": "Altieri, D. C. (2003). Blocking survivin to kill cancer cells. Methods Mol Biol 223, 533\u2013542.", "journal-title": "Methods Mol Biol"}, {"key": "41_CR3", "first-page": "1365", "volume": "63", "author": "J. Asakuma", "year": "2003", "unstructured": "Asakuma, J., Sumitomo, M., Asano, T., and Hayakawa, M. (2003). Selective Akt inactivation and tumor necrosis actor-related apoptosis-inducing ligand sensitization of renal cancer cells by low concentrations of paclitaxel. Cancer Res 63, 1365\u20131370.", "journal-title": "Cancer Res"}, {"key": "41_CR4", "doi-asserted-by": "publisher", "first-page": "420", "DOI": "10.1038/nrc821", "volume": "2", "author": "A. Ashkenazi", "year": "2002", "unstructured": "Ashkenazi, A. (2002). Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat Rev Cancer 2, 420\u2013430.", "journal-title": "Nat Rev Cancer"}, {"key": "41_CR5", "doi-asserted-by": "publisher", "first-page": "3621", "DOI": "10.1200/JCO.2007.15.7198", "volume": "26", "author": "A. Ashkenazi", "year": "2008", "unstructured": "Ashkenazi, A., Holland, P., and Eckhardt, S. G. (2008). Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL). J Clin Oncol 26, 3621\u20133630.", "journal-title": "J Clin Oncol"}, {"key": "41_CR6", "doi-asserted-by": "publisher", "first-page": "155", "DOI": "10.1172/JCI6926", "volume": "104", "author": "A. Ashkenazi", "year": "1999", "unstructured": "Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104, 155\u2013162.", "journal-title": "J Clin Invest"}, {"key": "41_CR7", "doi-asserted-by": "publisher", "first-page": "294", "DOI": "10.1038/sj.bjc.6604459", "volume": "99", "author": "D. M. Ashley", "year": "2008", "unstructured": "Ashley, D. M., Riffkin, C. D., Lovric, M. M., Mikeska, T., Dobrovic, A., Maxwell, J. A., Friedman, H. S., Drummond, K. J., Kaye, A. H., Gan, H. K., et al. (2008). In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs. Br J Cancer 99, 294\u2013304.", "journal-title": "Br J Cancer"}, {"key": "41_CR8", "doi-asserted-by": "crossref", "first-page": "3164", "DOI": "10.4049/jimmunol.167.6.3164", "volume": "167", "author": "T. M. Baetu", "year": "2001", "unstructured": "Baetu, T. M., Kwon, H., Sharma, S., Grandvaux, N., and Hiscott, J. (2001). Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J Immunol 167, 3164\u20133173.", "journal-title": "J Immunol"}, {"key": "41_CR9", "doi-asserted-by": "publisher", "first-page": "552", "DOI": "10.1038/316552a0", "volume": "316", "author": "B. Beutler", "year": "1985", "unstructured": "Beutler, B., Greenwald, D., Hulmes, J. D., Chang, M., Pan, Y. C., Mathison, J., Ulevitch, R., and Cerami, A. (1985). Identity of tumour necrosis factor and the macrophage-secreted factor cachectin. Nature 316, 552\u2013554.", "journal-title": "Nature"}, {"key": "41_CR10", "doi-asserted-by": "publisher", "first-page": "28189", "DOI": "10.1074/jbc.M704210200", "volume": "282", "author": "L. Bin", "year": "2007", "unstructured": "Bin, L., Thorburn, J., Thomas, L. R., Clark, P. E., Humphreys, R., and Thorburn, A. (2007). Tumor-derived mutations in the TRAIL receptor DR5 inhibit TRAIL signaling through the DR4 receptor by competing for ligand binding. J Biol Chem 282, 28189\u201328194.", "journal-title": "J Biol Chem"}, {"key": "41_CR11", "doi-asserted-by": "publisher", "first-page": "529", "DOI": "10.1016/S1097-2765(03)00051-0", "volume": "11", "author": "K. M. Boatright", "year": "2003", "unstructured": "Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J. E., Edris, W. A., Sutherlin, D. P., Green, D. R., and Salvesen, G. S. (2003). A unified model for apical caspase activation. Mol Cell 11, 529\u2013541.", "journal-title": "Mol Cell"}, {"key": "41_CR12", "doi-asserted-by": "publisher", "first-page": "7381", "DOI": "10.1038/sj.onc.1208888", "volume": "24", "author": "K. M. Bockbrader", "year": "2005", "unstructured": "Bockbrader, K. M., Tan, M., and Sun, Y. (2005). A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Oncogene 24, 7381\u20137388.", "journal-title": "Oncogene"}, {"key": "41_CR13", "doi-asserted-by": "publisher", "first-page": "241", "DOI": "10.1038/35008667", "volume": "2", "author": "J. L. Bodmer", "year": "2000", "unstructured": "Bodmer, J. L., Holler, N., Reynard, S., Vinciguerra, P., Schneider, P., Juo, P., Blenis, J., and Tschopp, J. (2000). TRAIL receptor-2 signals apoptosis through FADD and caspase-8. Nat Cell Biol 2, 241\u2013243.", "journal-title": "Nat Cell Biol"}, {"key": "41_CR14", "doi-asserted-by": "publisher", "first-page": "803", "DOI": "10.1016/S0092-8674(00)81265-9", "volume": "85", "author": "M. P. Boldin", "year": "1996", "unstructured": "Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. (1996). Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85, 803\u2013815.", "journal-title": "Cell"}, {"key": "41_CR15", "doi-asserted-by": "publisher", "first-page": "3666", "DOI": "10.1073/pnas.72.9.3666", "volume": "72", "author": "E. A. Carswell", "year": "1975", "unstructured": "Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., and Williamson, B. (1975). An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 72, 3666\u20133670.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "41_CR16", "doi-asserted-by": "publisher", "first-page": "253", "DOI": "10.1016/S1074-7613(00)80100-4", "volume": "11", "author": "S. S. Cha", "year": "1999", "unstructured": "Cha, S. S., Kim, M. S., Choi, Y. H., Sung, B. J., Shin, N. K., Shin, H. C., Sung, Y. C., and Oh, B. H. (1999). 2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity. Immunity 11, 253\u2013261.", "journal-title": "Immunity"}, {"key": "41_CR17", "doi-asserted-by": "publisher", "first-page": "4132", "DOI": "10.1093/emboj/cdg414", "volume": "22", "author": "D. W. Chang", "year": "2003", "unstructured": "Chang, D. W., Xing, Z., Capacio, V. L., Peter, M. E., and Yang, X. (2003). Interdimer processing mechanism of procaspase-8 activation. Embo J 22, 4132\u20134142.", "journal-title": "Embo J"}, {"key": "41_CR18", "doi-asserted-by": "publisher", "first-page": "821", "DOI": "10.1016/S1074-7613(00)80400-8", "volume": "7", "author": "P. M. Chaudhary", "year": "1997", "unstructured": "Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., and Hood, L. (1997). Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity 7, 821\u2013830.", "journal-title": "Immunity"}, {"key": "41_CR19", "doi-asserted-by": "publisher", "first-page": "1220", "DOI": "10.1182/blood-2006-04-015149", "volume": "109", "author": "D. Chauhan", "year": "2007", "unstructured": "Chauhan, D., Neri, P., Velankar, M., Podar, K., Hideshima, T., Fulciniti, M., Tassone, P., Raje, N., Mitsiades, C., Mitsiades, N., et al. (2007). Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM). Blood 109, 1220\u20131227.", "journal-title": "Blood"}, {"key": "41_CR20", "doi-asserted-by": "publisher", "first-page": "915", "DOI": "10.1038/sj.cdd.4401416", "volume": "11", "author": "M. Chawla-Sarkar", "year": "2004", "unstructured": "Chawla-Sarkar, M., Bae, S. I., Reu, F. J., Jacobs, B. S., Lindner, D. J., and Borden, E. C. (2004). Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 11, 915\u2013923.", "journal-title": "Cell Death Differ"}, {"key": "41_CR21", "doi-asserted-by": "publisher", "first-page": "235", "DOI": "10.1038/sj.neo.7900091", "volume": "2", "author": "J. Chen", "year": "2000", "unstructured": "Chen, J., Wu, W., Tahir, S. K., Kroeger, P. E., Rosenberg, S. H., Cowsert, L. M., Bennett, F., Krajewski, S., Krajewska, M., Welsh, K., et al. (2000). Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth. Neoplasia 2, 235\u2013241.", "journal-title": "Neoplasia"}, {"key": "41_CR22", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1016/0092-8674(95)90071-3", "volume": "81", "author": "A. M. Chinnaiyan", "year": "1995", "unstructured": "Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. (1995). FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505\u2013512.", "journal-title": "Cell"}, {"key": "41_CR23", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1128/MCB.22.3.724-736.2002", "volume": "22", "author": "C. Choi", "year": "2002", "unstructured": "Choi, C., Kutsch, O., Park, J., Zhou, T., Seol, D. W., and Benveniste, E. N. (2002). Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells. Mol Cell Biol 22, 724\u2013736.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR24", "doi-asserted-by": "publisher", "first-page": "18099", "DOI": "10.1073/pnas.0507329102", "volume": "102", "author": "L. Clancy", "year": "2005", "unstructured": "Clancy, L., Mruk, K., Archer, K., Woelfel, M., Mongkolsapaya, J., Screaton, G., Lenardo, M. J., and Chan, F. K. (2005). Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis. Proc Natl Acad Sci U S A 102, 18099\u201318104.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "41_CR25", "doi-asserted-by": "publisher", "first-page": "4409", "DOI": "10.1038/sj.onc.1202831", "volume": "18", "author": "G. Condorelli", "year": "1999", "unstructured": "Condorelli, G., Vigliotta, G., Cafieri, A., Trencia, A., Andalo, P., Oriente, F., Miele, C., Caruso, M., Formisano, P., and Beguinot, F. (1999). PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18, 4409\u20134415.", "journal-title": "Oncogene"}, {"key": "41_CR26", "doi-asserted-by": "publisher", "first-page": "3858", "DOI": "10.1093/emboj/17.14.3858", "volume": "17", "author": "G. Condorelli", "year": "1998", "unstructured": "Condorelli, G., Vigliotta, G., Iavarone, C., Caruso, M., Tocchetti, C. G., Andreozzi, F., Cafieri, A., Tecce, M. F., Formisano, P., Beguinot, L., and Beguinot, F. (1998). PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. Embo J 17, 3858\u20133866.", "journal-title": "Embo J"}, {"key": "41_CR27", "doi-asserted-by": "publisher", "first-page": "8994", "DOI": "10.1158/0008-5472.CAN-07-1045", "volume": "67", "author": "M. F. Corsten", "year": "2007", "unstructured": "Corsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., and Shah, K. (2007). MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Cancer Res 67, 8994\u20139000.", "journal-title": "Cancer Res"}, {"key": "41_CR28", "doi-asserted-by": "publisher", "first-page": "647", "DOI": "10.1038/nrc883", "volume": "2", "author": "S. Cory", "year": "2002", "unstructured": "Cory, S., and Adams, J. M. (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer 2, 647\u2013656.", "journal-title": "Nat Rev Cancer"}, {"key": "41_CR29", "doi-asserted-by": "publisher", "first-page": "2467", "DOI": "10.1002/1097-0142(19881215)62:12<2467::AID-CNCR2820621202>3.0.CO;2-5", "volume": "62", "author": "E. T. Creagan", "year": "1988", "unstructured": "Creagan, E. T., Kovach, J. S., Moertel, C. G., Frytak, S., and Kvols, L. K. (1988). A phase I clinical trial of recombinant human tumor necrosis factor. Cancer 62, 2467\u20132471.", "journal-title": "Cancer"}, {"key": "41_CR30", "first-page": "186", "volume": "23", "author": "P. J. Creaven", "year": "1989", "unstructured": "Creaven, P. J., Brenner, D. E., Cowens, J. W., Huben, R. P., Wolf, R. M., Takita, H., Arbuck, S. G., Razack, M. S., and Proefrock, A. D. (1989). A phase I clinical trial of recombinant human tumor necrosis factor given daily for five days. Cancer Chemother Pharmacol 23, 186\u2013191.", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "41_CR31", "doi-asserted-by": "crossref", "first-page": "1356", "DOI": "10.4049/jimmunol.168.3.1356", "volume": "168", "author": "E. Cretney", "year": "2002", "unstructured": "Cretney, E., Takeda, K., Yagita, H., Glaccum, M., Peschon, J. J., and Smyth, M. J. (2002). Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J Immunol 168, 1356\u20131361.", "journal-title": "J Immunol"}, {"key": "41_CR32", "doi-asserted-by": "crossref", "first-page": "532", "DOI": "10.1038/sj.bjc.6602363", "volume": "92", "author": "J. Cummings", "year": "2005", "unstructured": "Cummings, J., Ward, T. H., LaCasse, E., Lefebvre, C., St-Jean, M., Durkin, J., Ranson, M., and Dive, C. (2005). Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer 92, 532\u2013538.", "journal-title": "Br J Cancer"}, {"key": "41_CR33", "doi-asserted-by": "publisher", "first-page": "3006", "DOI": "10.1158/0008-5472.CAN-04-0046", "volume": "64", "author": "J. M. Cummins", "year": "2004", "unstructured": "Cummins, J. M., Kohli, M., Rago, C., Kinzler, K. W., Vogelstein, B., and Bunz, F. (2004). X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64, 3006\u20133008.", "journal-title": "Cancer Res"}, {"key": "41_CR34", "doi-asserted-by": "publisher", "first-page": "4037", "DOI": "10.1182/blood-2007-02-076075", "volume": "110", "author": "D. Daniel", "year": "2007", "unstructured": "Daniel, D., Yang, B., Lawrence, D. A., Totpal, K., Balter, I., Lee, W. P., Gogineni, A., Cole, M. J., Yee, S. F., Ross, S., and Ashkenazi, A. (2007). Cooperation of the proapoptotic receptor agonist rhApo2L/TRAIL with the CD20 antibody rituximab against non-Hodgkin lymphoma xenografts. Blood 110, 4037\u20134046.", "journal-title": "Blood"}, {"key": "41_CR35", "doi-asserted-by": "publisher", "first-page": "813", "DOI": "10.1016/S1074-7613(00)80399-4", "volume": "7", "author": "M. A. Degli-Esposti", "year": "1997", "unstructured": "Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., and Goodwin, R. G. (1997a). The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7, 813\u2013820.", "journal-title": "Immunity"}, {"key": "41_CR36", "doi-asserted-by": "publisher", "first-page": "1165", "DOI": "10.1084/jem.186.7.1165", "volume": "186", "author": "M. A. Degli-Esposti", "year": "1997", "unstructured": "Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C. P., DuBose, R. F., Goodwin, R. G., and Smith, C. A. (1997b). Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 186, 1165\u20131170.", "journal-title": "J Exp Med"}, {"key": "41_CR37", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1101/gad.949602", "volume": "16", "author": "Y. Deng", "year": "2002", "unstructured": "Deng, Y., Lin, Y., and Wu, X. (2002). TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Genes Dev 16, 33\u201345.", "journal-title": "Genes Dev"}, {"key": "41_CR38", "doi-asserted-by": "publisher", "first-page": "543", "DOI": "10.1016/S1097-2765(03)00059-5", "volume": "11", "author": "M. Donepudi", "year": "2003", "unstructured": "Donepudi, M., Mac Sweeney, A., Briand, C., and Grutter, M. G. (2003). Insights into the regulatory mechanism for caspase-8 activation. Mol Cell 11, 543\u2013549.", "journal-title": "Mol Cell"}, {"key": "41_CR39", "doi-asserted-by": "publisher", "first-page": "33", "DOI": "10.1016/S0092-8674(00)00008-8", "volume": "102", "author": "C. Du", "year": "2000", "unstructured": "Du, C., Fang, M., Li, Y., Li, L., and Wang, X. (2000). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33\u201342.", "journal-title": "Cell"}, {"key": "41_CR40", "first-page": "1314", "volume": "61", "author": "A. Eggert", "year": "2001", "unstructured": "Eggert, A., Grotzer, M. A., Zuzak, T. J., Wiewrodt, B. R., Ho, R., Ikegaki, N., and Brodeur, G. M. (2001). Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61, 1314\u20131319.", "journal-title": "Cancer Res"}, {"key": "41_CR41", "first-page": "7170", "volume": "62", "author": "M. Ehtesham", "year": "2002", "unstructured": "Ehtesham, M., Kabos, P., Gutierrez, M. A., Chung, N. H., Griffith, T. S., Black, K. L., and Yu, J. S. (2002). Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62, 7170\u20137174.", "journal-title": "Cancer Res"}, {"key": "41_CR42", "doi-asserted-by": "publisher", "first-page": "739", "DOI": "10.1038/sj.cgt.7700951", "volume": "13", "author": "S. ElOjeimy", "year": "2006", "unstructured": "ElOjeimy, S., McKillop, J. C., El-Zawahry, A. M., Holman, D. H., Liu, X., Schwartz, D. A., Day, T. A., Dong, J. Y., and Norris, J. S. (2006). FasL gene therapy: a new therapeutic modality for head and neck cancer. Cancer Gene Ther 13, 739\u2013745.", "journal-title": "Cancer Gene Ther"}, {"key": "41_CR43", "doi-asserted-by": "publisher", "first-page": "11469", "DOI": "10.1158/0008-5472.CAN-05-1724", "volume": "65", "author": "A. Eramo", "year": "2005", "unstructured": "Eramo, A., Pallini, R., Lotti, F., Sette, G., Patti, M., Bartucci, M., Ricci-Vitiani, L., Signore, M., Stassi, G., Larocca, L. M., et al. (2005). Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction. Cancer Res 65, 11469\u201311477.", "journal-title": "Cancer Res"}, {"key": "41_CR44", "first-page": "7133", "volume": "60", "author": "C. G. Ferreira", "year": "2000", "unstructured": "Ferreira, C. G., Span, S. W., Peters, G. J., Kruyt, F. A., and Giaccone, G. (2000). Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. Cancer Res 60, 7133\u20137141.", "journal-title": "Cancer Res"}, {"key": "41_CR45", "first-page": "1688", "volume": "7", "author": "M. J. Fisher", "year": "2001", "unstructured": "Fisher, M. J., Virmani, A. K., Wu, L., Aplenc, R., Harper, J. C., Powell, S. M., Rebbeck, T. R., Sidransky, D., Gazdar, A. F., and El-Deiry, W. S. (2001). Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer. Clin Cancer Res 7, 1688\u20131697.", "journal-title": "Clin Cancer Res"}, {"key": "41_CR46", "doi-asserted-by": "publisher", "first-page": "507", "DOI": "10.1016/j.ijrobp.2008.02.005", "volume": "71", "author": "J. B. Fiveash", "year": "2008", "unstructured": "Fiveash, J. B., Gillespie, G. Y., Oliver, P. G., Zhou, T., Belenky, M. L., and Buchsbaum, D. J. (2008). Enhancement of glioma radiotherapy and chemotherapy response with targeted antibody therapy against death receptor 5. Int J Radiat Oncol Biol Phys 71, 507\u2013516.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "41_CR47", "doi-asserted-by": "publisher", "first-page": "2283", "DOI": "10.1038/sj.onc.1205258", "volume": "21", "author": "S. Fulda", "year": "2002", "unstructured": "Fulda, S., Meyer, E., and Debatin, K. M. (2002a). Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21, 2283\u20132294.", "journal-title": "Oncogene"}, {"key": "41_CR48", "doi-asserted-by": "crossref", "first-page": "808", "DOI": "10.1038/nm735", "volume": "8", "author": "S. Fulda", "year": "2002", "unstructured": "Fulda, S., Wick, W., Weller, M., and Debatin, K. M. (2002b). Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8, 808\u2013815.", "journal-title": "Nat Med"}, {"key": "41_CR49", "doi-asserted-by": "publisher", "first-page": "1305", "DOI": "10.1200/JCO.2006.09.9804", "volume": "25", "author": "T. F. Gajewski", "year": "2007", "unstructured": "Gajewski, T. F. (2007). On the TRAIL toward death receptor-based cancer therapeutics. J Clin Oncol 25, 1305\u20131307.", "journal-title": "J Clin Oncol"}, {"key": "41_CR50", "first-page": "488", "volume": "62", "author": "E. M. Gibson", "year": "2002", "unstructured": "Gibson, E. M., Henson, E. S., Haney, N., Villanueva, J., and Gibson, S. B. (2002). Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res 62, 488\u2013496.", "journal-title": "Cancer Res"}, {"key": "41_CR51", "doi-asserted-by": "publisher", "first-page": "205", "DOI": "10.1128/MCB.20.1.205-212.2000", "volume": "20", "author": "S. B. Gibson", "year": "2000", "unstructured": "Gibson, S. B., Oyer, R., Spalding, A. C., Anderson, S. M., and Johnson, G. L. (2000). Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol Cell Biol 20, 205\u2013212.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR52", "doi-asserted-by": "publisher", "first-page": "3878", "DOI": "10.1093/emboj/17.14.3878", "volume": "17", "author": "A. Gross", "year": "1998", "unstructured": "Gross, A., Jockel, J., Wei, M. C., and Korsmeyer, S. J. (1998). Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. Embo J 17, 3878\u20133885.", "journal-title": "Embo J"}, {"key": "41_CR53", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1038/ncponc0426", "volume": "3", "author": "D. J. Grunhagen", "year": "2006", "unstructured": "Grunhagen, D. J., de Wilt, J. H., ten Hagen, T. L., and Eggermont, A. M. (2006). Technology insight: Utility of TNF-alpha-based isolated limb perfusion to avoid amputation of irresectable tumors of the extremities. Nat Clin Pract Oncol 3, 94\u2013103.", "journal-title": "Nat Clin Pract Oncol"}, {"key": "41_CR54", "doi-asserted-by": "publisher", "first-page": "2580", "DOI": "10.1158/0008-5472.CAN-03-2629", "volume": "64", "author": "F. Guo", "year": "2004", "unstructured": "Guo, F., Sigua, C., Tao, J., Bali, P., George, P., Li, Y., Wittmann, S., Moscinski, L., Atadja, P., and Bhalla, K. (2004). Cotreatment with histone deacetylase inhibitor LAQ824 enhances Apo-2L/tumor necrosis factor-related apoptosis inducing ligand-induced death inducing signaling complex activity and apoptosis of human acute leukemia cells. Cancer Res 64, 2580\u20132589.", "journal-title": "Cancer Res"}, {"key": "41_CR55", "first-page": "1162", "volume": "61", "author": "C. Hao", "year": "2001", "unstructured": "Hao, C., Beguinot, F., Condorelli, G., Trencia, A., Van Meir, E. G., Yong, V. W., Parney, I. F., Roa, W. H., and Petruk, K. C. (2001). Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apoptosis in human malignant glioma cells. Cancer Res 61, 1162\u20131170.", "journal-title": "Cancer Res"}, {"key": "41_CR56", "doi-asserted-by": "publisher", "first-page": "8502", "DOI": "10.1158/0008-5472.CAN-04-2599", "volume": "64", "author": "C. Hao", "year": "2004", "unstructured": "Hao, C., Song, J. H., Hsi, B., Lewis, J., Song, D. K., Petruk, K. C., Tyrrell, D. L., and Kneteman, N. M. (2004). TRAIL inhibits tumor growth but is nontoxic to human hepatocytes in chimeric mice. Cancer Res 64, 8502\u20138506.", "journal-title": "Cancer Res"}, {"key": "41_CR57", "doi-asserted-by": "publisher", "first-page": "34743", "DOI": "10.1074/jbc.M105693200", "volume": "276", "author": "N. Harper", "year": "2001", "unstructured": "Harper, N., Farrow, S. N., Kaptein, A., Cohen, G. M., and MacFarlane, M. (2001). Modulation of tumor necrosis factor apoptosis-inducing ligand- induced NF-kappa B activation by inhibition of apical caspases. J Biol Chem 276, 34743\u201334752.", "journal-title": "J Biol Chem"}, {"key": "41_CR58", "doi-asserted-by": "publisher", "first-page": "5477", "DOI": "10.1038/sj.onc.1203936", "volume": "19", "author": "S. Hinz", "year": "2000", "unstructured": "Hinz, S., Trauzold, A., Boenicke, L., Sandberg, C., Beckmann, S., Bayer, E., Walczak, H., Kalthoff, H., and Ungefroren, H. (2000). Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene 19, 5477\u20135486.", "journal-title": "Oncogene"}, {"key": "41_CR59", "doi-asserted-by": "publisher", "first-page": "4233", "DOI": "10.1021/jm0002230", "volume": "43", "author": "T. Honda", "year": "2000", "unstructured": "Honda, T., Rounds, B. V., Bore, L., Finlay, H. J., Favaloro, F. G., Jr., Suh, N., Wang, Y., Sporn, M. B., and Gribble, G. W. (2000). Synthetic oleanane and ursane triterpenoids with modified rings A and C: a series of highly active inhibitors of nitric oxide production in mouse macrophages. J Med Chem 43, 4233\u20134246.", "journal-title": "J Med Chem"}, {"key": "41_CR60", "first-page": "4315", "volume": "60", "author": "S. Hopkins-Donaldson", "year": "2000", "unstructured": "Hopkins-Donaldson, S., Bodmer, J. L., Bourloud, K. B., Brognara, C. B., Tschopp, J., and Gross, N. (2000). Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res 60, 4315\u20134319.", "journal-title": "Cancer Res"}, {"key": "41_CR61", "doi-asserted-by": "publisher", "first-page": "387", "DOI": "10.1016/S1074-7613(00)80252-6", "volume": "4", "author": "H. Hsu", "year": "1996", "unstructured": "Hsu, H., Huang, J., Shu, H. B., Baichwal, V., and Goeddel, D. V. (1996a). TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387\u2013396.", "journal-title": "Immunity"}, {"key": "41_CR62", "doi-asserted-by": "publisher", "first-page": "299", "DOI": "10.1016/S0092-8674(00)80984-8", "volume": "84", "author": "H. Hsu", "year": "1996", "unstructured": "Hsu, H., Shu, H. B., Pan, M. G., and Goeddel, D. V. (1996b). TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84, 299\u2013308.", "journal-title": "Cell"}, {"key": "41_CR63", "doi-asserted-by": "publisher", "first-page": "127", "DOI": "10.1007/978-1-4020-6554-5_7", "volume": "615", "author": "R. C. Humphreys", "year": "2008", "unstructured": "Humphreys, R. C., and Halpern, W. (2008). Trail receptors: targets for cancer therapy. Adv Exp Med Biol 615, 127\u2013158.", "journal-title": "Adv Exp Med Biol"}, {"key": "41_CR64", "doi-asserted-by": "publisher", "first-page": "4799", "DOI": "10.1158/0008-5472.CAN-04-3319", "volume": "65", "author": "M. L. Hyer", "year": "2005", "unstructured": "Hyer, M. L., Croxton, R., Krajewska, M., Krajewski, S., Kress, C. L., Lu, M., Suh, N., Sporn, M. B., Cryns, V. L., Zapata, J. M., and Reed, J. C. (2005). Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells. Cancer Res 65, 4799\u20134808.", "journal-title": "Cancer Res"}, {"key": "41_CR65", "doi-asserted-by": "publisher", "first-page": "954", "DOI": "10.1038/91000", "volume": "7", "author": "K. Ichikawa", "year": "2001", "unstructured": "Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., and Zhou, T. (2001). Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med 7, 954\u2013960.", "journal-title": "Nat Med"}, {"key": "41_CR66", "doi-asserted-by": "publisher", "first-page": "190", "DOI": "10.1038/40657", "volume": "388", "author": "M. Irmler", "year": "1997", "unstructured": "Irmler, M., Thome, M., Hahne, M., Schneider, P., Hofmann, K., Steiner, V., Bodmer, J. L., Schroter, M., Burns, K., Mattmann, C., et al. (1997). Inhibition of death receptor signals by cellular FLIP. Nature 388, 190\u2013195.", "journal-title": "Nature"}, {"key": "41_CR67", "doi-asserted-by": "publisher", "first-page": "469", "DOI": "10.1111/j.1750-3639.1999.tb00536.x", "volume": "9", "author": "N. Ishii", "year": "1999", "unstructured": "Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A. C., and Van Meir, E. G. (1999). Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9, 469\u2013479.", "journal-title": "Brain Pathol"}, {"key": "41_CR68", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1016/0092-8674(91)90614-5", "volume": "66", "author": "N. Itoh", "year": "1991", "unstructured": "Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233\u2013243.", "journal-title": "Cell"}, {"key": "41_CR69", "first-page": "4624", "volume": "91", "author": "I. Jeremias", "year": "1998", "unstructured": "Jeremias, I., Kupatt, C., Baumann, B., Herr, I., Wirth, T., and Debatin, K. M. (1998). Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 91, 4624\u20134631.", "journal-title": "Blood"}, {"key": "41_CR70", "doi-asserted-by": "publisher", "first-page": "4900", "DOI": "10.1158/0008-5472.CAN-04-0408", "volume": "64", "author": "H. Jin", "year": "2004", "unstructured": "Jin, H., Yang, R., Fong, S., Totpal, K., Lawrence, D., Zheng, Z., Ross, J., Koeppen, H., Schwall, R., and Ashkenazi, A. (2004). Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival. Cancer Res 64, 4900\u20134905.", "journal-title": "Cancer Res"}, {"key": "41_CR71", "doi-asserted-by": "publisher", "first-page": "564", "DOI": "10.1038/75045", "volume": "6", "author": "M. Jo", "year": "2000", "unstructured": "Jo, M., Kim, T. H., Seol, D. W., Esplen, J. E., Dorko, K., Billiar, T. R., and Strom, S. C. (2000). Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand. Nat Med 6, 564\u2013567.", "journal-title": "Nat Med"}, {"key": "41_CR72", "doi-asserted-by": "publisher", "first-page": "957", "DOI": "10.1158/1535-7163.MCT-06-0634", "volume": "6", "author": "C. A. Karikari", "year": "2007", "unstructured": "Karikari, C. A., Roy, I., Tryggestad, E., Feldmann, G., Pinilla, C., Welsh, K., Reed, J. C., Armour, E. P., Wong, J., Herman, J., et al. (2007). Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein. Mol Cancer Ther 6, 957\u2013966.", "journal-title": "Mol Cancer Ther"}, {"key": "41_CR73", "doi-asserted-by": "publisher", "first-page": "640", "DOI": "10.1016/S0960-9822(00)00512-1", "volume": "10", "author": "T. Kataoka", "year": "2000", "unstructured": "Kataoka, T., Budd, R. C., Holler, N., Thome, M., Martinon, F., Irmler, M., Burns, K., Hahne, M., Kennedy, N., Kovacsovics, M., and Tschopp, J. (2000). The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol 10, 640\u2013648.", "journal-title": "Curr Biol"}, {"key": "41_CR74", "doi-asserted-by": "publisher", "first-page": "2627", "DOI": "10.1128/MCB.24.7.2627-2636.2004", "volume": "24", "author": "T. Kataoka", "year": "2004", "unstructured": "Kataoka, T., and Tschopp, J. (2004). N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol Cell Biol 24, 2627\u20132636.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR75", "first-page": "734", "volume": "59", "author": "M. M. Keane", "year": "1999", "unstructured": "Keane, M. M., Ettenberg, S. A., Nau, M. M., Russell, E. K., and Lipkowitz, S. (1999). Chemotherapy augments TRAIL-induced apoptosis in breast cell lines. Cancer Res 59, 734\u2013741.", "journal-title": "Cancer Res"}, {"key": "41_CR76", "doi-asserted-by": "publisher", "first-page": "708", "DOI": "10.1016/S0016-5085(03)01059-X", "volume": "125", "author": "H. S. Kim", "year": "2003", "unstructured": "Kim, H. S., Lee, J. W., Soung, Y. H., Park, W. S., Kim, S. Y., Lee, J. H., Park, J. Y., Cho, Y. G., Kim, C. J., Jeong, S. W., et al. (2003). Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125, 708\u2013715.", "journal-title": "Gastroenterology"}, {"key": "41_CR77", "doi-asserted-by": "crossref", "first-page": "5579", "DOI": "10.1002/j.1460-2075.1995.tb00245.x", "volume": "14", "author": "F. C. Kischkel", "year": "1995", "unstructured": "Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., and Peter, M. E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J 14, 5579\u20135588.", "journal-title": "Embo J"}, {"key": "41_CR78", "doi-asserted-by": "publisher", "first-page": "611", "DOI": "10.1016/S1074-7613(00)80212-5", "volume": "12", "author": "F. C. Kischkel", "year": "2000", "unstructured": "Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., and Ashkenazi, A. (2000). Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. Immunity 12, 611\u2013620.", "journal-title": "Immunity"}, {"key": "41_CR79", "doi-asserted-by": "publisher", "first-page": "46639", "DOI": "10.1074/jbc.M105102200", "volume": "276", "author": "F. C. Kischkel", "year": "2001", "unstructured": "Kischkel, F. C., Lawrence, D. A., Tinel, A., LeBlanc, H., Virmani, A., Schow, P., Gazdar, A., Blenis, J., Arnott, D., and Ashkenazi, A. (2001). Death receptor recruitment of endogenous caspase-10 and apoptosis initiation in the absence of caspase-8. J Biol Chem 276, 46639\u201346646.", "journal-title": "J Biol Chem"}, {"key": "41_CR80", "doi-asserted-by": "publisher", "first-page": "193", "DOI": "10.1089/108729002760220798", "volume": "12", "author": "R. J. Klasa", "year": "2002", "unstructured": "Klasa, R. J., Gillum, A. M., Klem, R. E., and Frankel, S. R. (2002). Oblimersen Bcl-2 antisense: facilitating apoptosis in anticancer treatment. Antisense Nucleic Acid Drug Dev 12, 193\u2013213.", "journal-title": "Antisense Nucleic Acid Drug Dev"}, {"key": "41_CR81", "doi-asserted-by": "publisher", "first-page": "5789", "DOI": "10.1038/sj.onc.1204810", "volume": "20", "author": "M. J. Knight", "year": "2001", "unstructured": "Knight, M. J., Riffkin, C. D., Muscat, A. M., Ashley, D. M., and Hawkins, C. J. (2001). Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 20, 5789\u20135798.", "journal-title": "Oncogene"}, {"key": "41_CR82", "doi-asserted-by": "publisher", "first-page": "3403", "DOI": "10.1158/1078-0432.CCR-07-0251", "volume": "13", "author": "R. Koschny", "year": "2007", "unstructured": "Koschny, R., Holland, H., Sykora, J., Haas, T. L., Sprick, M. R., Ganten, T. M., Krupp, W., Bauer, M., Ahnert, P., Meixensberger, J., and Walczak, H. (2007). Bortezomib sensitizes primary human astrocytoma cells of WHO grades I to IV for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Clin Cancer Res 13, 3403\u20133412.", "journal-title": "Clin Cancer Res"}, {"key": "41_CR83", "doi-asserted-by": "publisher", "first-page": "3964", "DOI": "10.1128/MCB.21.12.3964-3973.2001", "volume": "21", "author": "S. Kreuz", "year": "2001", "unstructured": "Kreuz, S., Siegmund, D., Scheurich, P., and Wajant, H. (2001). NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 21, 3964\u20133973.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR84", "doi-asserted-by": "publisher", "first-page": "3552", "DOI": "10.1091/mbc.E04-11-1007", "volume": "16", "author": "J. Krueger", "year": "2005", "unstructured": "Krueger, J., Chou, F. L., Glading, A., Schaefer, E., and Ginsberg, M. H. (2005). Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol Biol Cell 16, 3552\u20133561.", "journal-title": "Mol Biol Cell"}, {"key": "41_CR85", "doi-asserted-by": "publisher", "first-page": "571", "DOI": "10.1038/sj.onc.1209841", "volume": "26", "author": "K. Ferla-Bruhl La", "year": "2007", "unstructured": "La Ferla-Bruhl, K., Westhoff, M. A., Karl, S., Kasperczyk, H., Zwacka, R. M., Debatin, K. M., and Fulda, S. (2007). NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. Oncogene 26, 571\u2013582.", "journal-title": "Oncogene"}, {"key": "41_CR86", "first-page": "1645", "volume": "61", "author": "S. Lacour", "year": "2001", "unstructured": "Lacour, S., Hammann, A., Wotawa, A., Corcos, L., Solary, E., and Dimanche-Boitrel, M. T. (2001). Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis. Cancer Res 61, 1645\u20131651.", "journal-title": "Cancer Res"}, {"key": "41_CR87", "doi-asserted-by": "publisher", "first-page": "383", "DOI": "10.1038/86397", "volume": "7", "author": "D. Lawrence", "year": "2001", "unstructured": "Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001). Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7, 383\u2013385.", "journal-title": "Nat Med"}, {"key": "41_CR88", "doi-asserted-by": "publisher", "first-page": "274", "DOI": "10.1038/nm0302-274", "volume": "8", "author": "H. LeBlanc", "year": "2002", "unstructured": "LeBlanc, H., Lawrence, D., Varfolomeev, E., Totpal, K., Morlan, J., Schow, P., Fong, S., Schwall, R., Sinicropi, D., and Ashkenazi, A. (2002). Tumor-cell resistance to death receptor--induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 8, 274\u2013281.", "journal-title": "Nat Med"}, {"key": "41_CR89", "first-page": "5683", "volume": "59", "author": "S. H. Lee", "year": "1999", "unstructured": "Lee, S. H., Shin, M. S., Kim, H. S., Lee, H. K., Park, W. S., Kim, S. Y., Lee, J. H., Han, S. Y., Park, J. Y., Oh, R. R., et al. (1999). Alterations of the DR5/TRAIL receptor 2 gene in non-small cell lung cancers. Cancer Res 59, 5683\u20135686.", "journal-title": "Cancer Res"}, {"key": "41_CR90", "doi-asserted-by": "publisher", "first-page": "399", "DOI": "10.1038/sj.onc.1204103", "volume": "20", "author": "S. H. Lee", "year": "2001", "unstructured": "Lee, S. H., Shin, M. S., Kim, H. S., Lee, H. K., Park, W. S., Kim, S. Y., Lee, J. H., Han, S. Y., Park, J. Y., Oh, R. R., et al. (2001). Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma. Oncogene 20, 399\u2013403.", "journal-title": "Oncogene"}, {"key": "41_CR91", "doi-asserted-by": "publisher", "first-page": "391", "DOI": "10.1007/BF00257449", "volume": "24", "author": "H. Lenk", "year": "1989", "unstructured": "Lenk, H., Tanneberger, S., Muller, U., Ebert, J., and Shiga, T. (1989). Phase II clinical trial of high-dose recombinant human tumor necrosis factor. Cancer Chemother Pharmacol 24, 391\u2013392.", "journal-title": "Cancer Chemother Pharmacol"}, {"key": "41_CR92", "doi-asserted-by": "publisher", "first-page": "121", "DOI": "10.1038/nrc2297", "volume": "8", "author": "A. G. Letai", "year": "2008", "unstructured": "Letai, A. G. (2008). Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer 8, 121\u2013132.", "journal-title": "Nat Rev Cancer"}, {"key": "41_CR93", "doi-asserted-by": "publisher", "first-page": "2830", "DOI": "10.1073/pnas.88.7.2830", "volume": "88", "author": "M. Lewis", "year": "1991", "unstructured": "Lewis, M., Tartaglia, L. A., Lee, A., Bennett, G. L., Rice, G. C., Wong, G. H., Chen, E. Y., and Goeddel, D. V. (1991). Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sci U S A 88, 2830\u20132834.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "41_CR94", "doi-asserted-by": "publisher", "first-page": "491", "DOI": "10.1016/S0092-8674(00)81590-1", "volume": "94", "author": "H. Li", "year": "1998", "unstructured": "Li, H., Zhu, H., Xu, C. J., and Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491\u2013501.", "journal-title": "Cell"}, {"key": "41_CR95", "doi-asserted-by": "publisher", "first-page": "1471", "DOI": "10.1126/science.1098231", "volume": "305", "author": "L. Li", "year": "2004", "unstructured": "Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., and Harran, P. G. (2004). A small molecule Smac mimic potentiates TRAIL- and TNFalpha-mediated cell death. Science 305, 1471\u20131474.", "journal-title": "Science"}, {"key": "41_CR96", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1016/S0092-8674(00)80434-1", "volume": "91", "author": "P. Li", "year": "1997", "unstructured": "Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479\u2013489.", "journal-title": "Cell"}, {"key": "41_CR97", "doi-asserted-by": "publisher", "first-page": "2716", "DOI": "10.1158/1078-0432.CCR-05-1980", "volume": "12", "author": "Y. C. Li", "year": "2006", "unstructured": "Li, Y. C., Tzeng, C. C., Song, J. H., Tsia, F. J., Hsieh, L. J., Liao, S. J., Tsai, C. H., Van Meir, E. G., Hao, C., and Lin, C. C. (2006). Genomic alterations in human malignant glioma cells associate with the cell resistance to the combination treatment with tumor necrosis factor-related apoptosis-inducing ligand and chemotherapy. Clin Cancer Res 12, 2716\u20132729.", "journal-title": "Clin Cancer Res"}, {"key": "41_CR98", "doi-asserted-by": "publisher", "first-page": "6638", "DOI": "10.1128/MCB.20.18.6638-6645.2000", "volume": "20", "author": "Y. Lin", "year": "2000", "unstructured": "Lin, Y., Devin, A., Cook, A., Keane, M. M., Kelliher, M., Lipkowitz, S., and Liu, Z. G. (2000). The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase. Mol Cell Biol 20, 6638\u20136645.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR99", "doi-asserted-by": "publisher", "first-page": "9169", "DOI": "10.1158/0008-5472.CAN-05-0939", "volume": "65", "author": "X. Liu", "year": "2005", "unstructured": "Liu, X., Yue, P., Khuri, F. R., and Sun, S. Y. (2005). Decoy receptor 2 (DcR2) is a p53 target gene and regulates chemosensitivity. Cancer Res 65, 9169\u20139175.", "journal-title": "Cancer Res"}, {"key": "41_CR100", "doi-asserted-by": "publisher", "first-page": "1769", "DOI": "10.1093/jnci/djh322", "volume": "96", "author": "X. Liu", "year": "2004", "unstructured": "Liu, X., Yue, P., Zhou, Z., Khuri, F. R., and Sun, S. Y. (2004). Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells. J Natl Cancer Inst 96, 1769\u20131780.", "journal-title": "J Natl Cancer Inst"}, {"key": "41_CR101", "doi-asserted-by": "publisher", "first-page": "175", "DOI": "10.1016/S0092-8674(00)80197-X", "volume": "89", "author": "X. Liu", "year": "1997", "unstructured": "Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89, 175\u2013184.", "journal-title": "Cell"}, {"key": "41_CR102", "doi-asserted-by": "publisher", "first-page": "11878", "DOI": "10.1158/0008-5472.CAN-06-2354", "volume": "66", "author": "W. Lu", "year": "2006", "unstructured": "Lu, W., Sun, Q., Wan, J., She, Z., and Jiang, X. G. (2006). Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res 66, 11878\u201311887.", "journal-title": "Cancer Res"}, {"key": "41_CR103", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1016/S0092-8674(00)81589-5", "volume": "94", "author": "X. Luo", "year": "1998", "unstructured": "Luo, X., Budihardjo, I., Zou, H., Slaughter, C., and Wang, X. (1998). Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481\u2013490.", "journal-title": "Cell"}, {"key": "41_CR104", "doi-asserted-by": "publisher", "first-page": "7333", "DOI": "10.1038/sj.onc.1209765", "volume": "25", "author": "H. Malhi", "year": "2006", "unstructured": "Malhi, H., and Gores, G. J. (2006). TRAIL resistance results in cancer progression: a TRAIL to perdition? Oncogene 25, 7333\u20137335.", "journal-title": "Oncogene"}, {"key": "41_CR105", "doi-asserted-by": "publisher", "first-page": "973", "DOI": "10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T", "volume": "28", "author": "S. M. Mariani", "year": "1998", "unstructured": "Mariani, S. M., and Krammer, P. H. (1998). Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 28, 973\u2013982.", "journal-title": "Eur J Immunol"}, {"key": "41_CR106", "doi-asserted-by": "publisher", "first-page": "1003", "DOI": "10.1016/S0960-9822(06)00422-2", "volume": "7", "author": "S. A. Marsters", "year": "1997", "unstructured": "Marsters, S. A., Sheridan, J. P., Pitti, R. M., Huang, A., Skubatch, M., Baldwin, D., Yuan, J., Gurney, A., Goddard, A. D., Godowski, P., and Ashkenazi, A. (1997). A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol 7, 1003\u20131006.", "journal-title": "Curr Biol"}, {"key": "41_CR107", "doi-asserted-by": "publisher", "first-page": "11447", "DOI": "10.1158/0008-5472.CAN-05-1494", "volume": "65", "author": "S. Martin", "year": "2005", "unstructured": "Martin, S., Phillips, D. C., Szekely-Szucs, K., Elghazi, L., Desmots, F., and Houghton, J. A. (2005). Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Cancer Res 65, 11447\u201311458.", "journal-title": "Cancer Res"}, {"key": "41_CR108", "doi-asserted-by": "publisher", "first-page": "14939", "DOI": "10.1074/jbc.M100399200", "volume": "276", "author": "E. R. McDonald", "year": "2001", "unstructured": "McDonald, E. R., 3rd, Chui, P. C., Martelli, P. F., Dicker, D. T., and El-Deiry, W. S. (2001). Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signaling. J Biol Chem 276, 14939\u201314945.", "journal-title": "J Biol Chem"}, {"key": "41_CR109", "doi-asserted-by": "publisher", "first-page": "2794", "DOI": "10.1093/emboj/16.10.2794", "volume": "16", "author": "J. P. Medema", "year": "1997", "unstructured": "Medema, J. P., Scaffidi, C., Kischkel, F. C., Shevchenko, A., Mann, M., Krammer, P. H., and Peter, M. E. (1997). FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). Embo J 16, 2794\u20132804.", "journal-title": "Embo J"}, {"key": "41_CR110", "doi-asserted-by": "publisher", "first-page": "7046", "DOI": "10.1128/MCB.00520-06", "volume": "26", "author": "D. Merino", "year": "2006", "unstructured": "Merino, D., Lalaoui, N., Morizot, A., Schneider, P., Solary, E., and Micheau, O. (2006). Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. Mol Cell Biol 26, 7046\u20137055.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR111", "doi-asserted-by": "publisher", "first-page": "5299", "DOI": "10.1128/MCB.21.16.5299-5305.2001", "volume": "21", "author": "O. Micheau", "year": "2001", "unstructured": "Micheau, O., Lens, S., Gaide, O., Alevizopoulos, K., and Tschopp, J. (2001). NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol 21, 5299\u20135305.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR112", "doi-asserted-by": "publisher", "first-page": "795", "DOI": "10.1182/blood.V98.3.795", "volume": "98", "author": "C. S. Mitsiades", "year": "2001", "unstructured": "Mitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., and Anderson, K. C. (2001). TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications. Blood 98, 795\u2013804.", "journal-title": "Blood"}, {"key": "41_CR113", "first-page": "919", "volume": "30", "author": "Y. Mizutani", "year": "2007", "unstructured": "Mizutani, Y., Nakanishi, H., Li, Y. N., Matsubara, H., Yamamoto, K., Sato, N., Shiraishi, T., Nakamura, T., Mikami, K., Okihara, K., et al. (2007). Overexpression of XIAP expression in renal cell carcinoma predicts a worse prognosis. Int J Oncol 30, 919\u2013925.", "journal-title": "Int J Oncol"}, {"key": "41_CR114", "first-page": "3", "volume": "160", "author": "J. Mongkolsapaya", "year": "1998", "unstructured": "Mongkolsapaya, J., Cowper, A. E., Xu, X. N., Morris, G., McMichael, A. J., Bell, J. I., and Screaton, G. R. (1998). Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL. J Immunol 160, 3\u20136.", "journal-title": "J Immunol"}, {"key": "41_CR115", "doi-asserted-by": "publisher", "first-page": "3757", "DOI": "10.1038/sj.onc.1204504", "volume": "20", "author": "A. Munshi", "year": "2001", "unstructured": "Munshi, A., Pappas, G., Honda, T., McDonnell, T. J., Younes, A., Li, Y., and Meyn, R. E. (2001). TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2. Oncogene 20, 3757\u20133765.", "journal-title": "Oncogene"}, {"key": "41_CR116", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.1016/S0092-8674(00)81266-0", "volume": "85", "author": "M. Muzio", "year": "1996", "unstructured": "Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex. Cell 85, 817\u2013827.", "journal-title": "Cell"}, {"key": "41_CR117", "doi-asserted-by": "publisher", "first-page": "2926", "DOI": "10.1074/jbc.273.5.2926", "volume": "273", "author": "M. Muzio", "year": "1998", "unstructured": "Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S., and Dixit, V. M. (1998). An induced proximity model for caspase-8 activation. J Biol Chem 273, 2926\u20132930.", "journal-title": "J Biol Chem"}, {"key": "41_CR118", "doi-asserted-by": "publisher", "first-page": "407", "DOI": "10.3171/jns.2007.106.3.407", "volume": "106", "author": "M. Nagane", "year": "2007", "unstructured": "Nagane, M., Cavenee, W. K., and Shiokawa, Y. (2007). Synergistic cytotoxicity through the activation of multiple apoptosis pathways in human glioma cells induced by combined treatment with ionizing radiation and tumor necrosis factor-related apoptosis-inducing ligand. J Neurosurg 106, 407\u2013416.", "journal-title": "J Neurosurg"}, {"key": "41_CR119", "first-page": "847", "volume": "60", "author": "M. Nagane", "year": "2000", "unstructured": "Nagane, M., Pan, G., Weddle, J. J., Dixit, V. M., Cavenee, W. K., and Huang, H. J. (2000). Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 60, 847\u2013853.", "journal-title": "Cancer Res"}, {"key": "41_CR120", "doi-asserted-by": "publisher", "first-page": "502", "DOI": "10.1038/74972", "volume": "6", "author": "S. Nagata", "year": "2000", "unstructured": "Nagata, S. (2000). Steering anti-cancer drugs away from the TRAIL. Nat Med 6, 502\u2013503.", "journal-title": "Nat Med"}, {"key": "41_CR121", "doi-asserted-by": "crossref", "first-page": "147", "DOI": "10.1038/sj.gt.3302845", "volume": "14", "author": "U. Naumann", "year": "2007", "unstructured": "Naumann, U., Bahr, O., Wolburg, H., Altenberend, S., Wick, W., Liston, P., Ashkenazi, A., and Weller, M. (2007). Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice. Gene Ther 14, 147\u2013161.", "journal-title": "Gene Ther"}, {"key": "41_CR122", "first-page": "759", "volume": "61", "author": "R. Nimmanapalli", "year": "2001", "unstructured": "Nimmanapalli, R., Perkins, C. L., Orlando, M., O'Bryan, E., Nguyen, D., and Bhalla, K. N. (2001). Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 61, 759\u2013763.", "journal-title": "Cancer Res"}, {"key": "41_CR123", "doi-asserted-by": "publisher", "first-page": "827", "DOI": "10.1016/S0140-6736(00)02659-3", "volume": "356", "author": "R. Nitsch", "year": "2000", "unstructured": "Nitsch, R., Bechmann, I., Deisz, R. A., Haas, D., Lehmann, T. N., Wendling, U., and Zipp, F. (2000). Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356, 827\u2013828.", "journal-title": "Lancet"}, {"key": "41_CR124", "doi-asserted-by": "publisher", "first-page": "806", "DOI": "10.1038/364806a0", "volume": "364", "author": "J. Ogasawara", "year": "1993", "unstructured": "Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., and Nagata, S. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364, 806\u2013809.", "journal-title": "Nature"}, {"key": "41_CR125", "doi-asserted-by": "publisher", "first-page": "2034", "DOI": "10.1038/sj.onc.1206290", "volume": "22", "author": "T. Ohtsuka", "year": "2003", "unstructured": "Ohtsuka, T., Buchsbaum, D., Oliver, P., Makhija, S., Kimberly, R., and Zhou, T. (2003). Synergistic induction of tumor cell apoptosis by death receptor antibody and chemotherapy agent through JNK/p38 and mitochondrial death pathway. Oncogene 22, 2034\u20132044.", "journal-title": "Oncogene"}, {"key": "41_CR126", "doi-asserted-by": "publisher", "first-page": "41", "DOI": "10.1016/S0014-5793(98)00135-5", "volume": "424", "author": "G. Pan", "year": "1998", "unstructured": "Pan, G., Ni, J., Yu, G., Wei, Y. F., and Dixit, V. M. (1998). TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling. FEBS Lett 424, 41\u201345.", "journal-title": "FEBS Lett"}, {"key": "41_CR127", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1126/science.276.5309.111", "volume": "276", "author": "G. Pan", "year": "1997", "unstructured": "Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., and Dixit, V. M. (1997). The receptor for the cytotoxic ligand TRAIL. Science 276, 111\u2013113.", "journal-title": "Science"}, {"key": "41_CR128", "doi-asserted-by": "publisher", "first-page": "8809", "DOI": "10.1128/MCB.25.20.8809-8823.2005", "volume": "25", "author": "A. Panner", "year": "2005", "unstructured": "Panner, A., James, C. D., Berger, M. S., and Pieper, R. O. (2005). mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol Cell Biol 25, 8809\u20138823.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR129", "doi-asserted-by": "publisher", "first-page": "9482", "DOI": "10.1158/0008-5472.CAN-07-0569", "volume": "67", "author": "A. Panner", "year": "2007", "unstructured": "Panner, A., Murray, J. C., Berger, M. S., and Pieper, R. O. (2007). Heat shock protein 90alpha recruits FLIPS to the death-inducing signaling complex and contributes to TRAIL resistance in human glioma. Cancer Res 67, 9482\u20139489.", "journal-title": "Cancer Res"}, {"key": "41_CR130", "doi-asserted-by": "publisher", "first-page": "1219", "DOI": "10.1053/gast.2001.28663", "volume": "121", "author": "W. S. Park", "year": "2001", "unstructured": "Park, W. S., Lee, J. H., Shin, M. S., Park, J. Y., Kim, H. S., Kim, Y. S., Park, C. H., Lee, S. K., Lee, S. H., Lee, S. N., et al. (2001). Inactivating mutations of KILLER/DR5 gene in gastric cancers. Gastroenterology 121, 1219\u20131225.", "journal-title": "Gastroenterology"}, {"key": "41_CR131", "doi-asserted-by": "publisher", "first-page": "724", "DOI": "10.1038/312724a0", "volume": "312", "author": "D. Pennica", "year": "1984", "unstructured": "Pennica, D., Nedwin, G. E., Hayflick, J. S., Seeburg, P. H., Derynck, R., Palladino, M. A., Kohr, W. J., Aggarwal, B. B., and Goeddel, D. V. (1984). Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724\u2013729.", "journal-title": "Nature"}, {"key": "41_CR132", "doi-asserted-by": "publisher", "first-page": "12687", "DOI": "10.1074/jbc.271.22.12687", "volume": "271", "author": "R. M. Pitti", "year": "1996", "unstructured": "Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., and Ashkenazi, A. (1996). Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271, 12687\u201312690.", "journal-title": "J Biol Chem"}, {"key": "41_CR133", "doi-asserted-by": "publisher", "first-page": "6187", "DOI": "10.1158/1078-0432.CCR-07-0950", "volume": "13", "author": "R. Plummer", "year": "2007", "unstructured": "Plummer, R., Attard, G., Pacey, S., Li, L., Razak, A., Perrett, R., Barrett, M., Judson, I., Kaye, S., Fox, N. L., et al. (2007). Phase 1 and pharmacokinetic study of lexatumumab in patients with advanced cancers. Clin Cancer Res 13, 6187\u20136194.", "journal-title": "Clin Cancer Res"}, {"key": "41_CR134", "doi-asserted-by": "publisher", "first-page": "1813", "DOI": "10.1038/sj.cdd.4402177", "volume": "14", "author": "T. W. Poh", "year": "2007", "unstructured": "Poh, T. W., Huang, S., Hirpara, J. L., and Pervaiz, S. (2007). LY303511 amplifies TRAIL-induced apoptosis in tumor cells by enhancing DR5 oligomerization, DISC assembly, and mitochondrial permeabilization. Cell Death Differ 14, 1813\u20131825.", "journal-title": "Cell Death Differ"}, {"key": "41_CR135", "first-page": "1362", "volume": "7", "author": "I. F. Pollack", "year": "2001", "unstructured": "Pollack, I. F., Erff, M., and Ashkenazi, A. (2001). Direct stimulation of apoptotic signaling by soluble Apo2l/tumor necrosis factor-related apoptosis-inducing ligand leads to selective killing of glioma cells. Clin Cancer Res 7, 1362\u20131369.", "journal-title": "Clin Cancer Res"}, {"key": "41_CR136", "doi-asserted-by": "publisher", "first-page": "967", "DOI": "10.1126/science.275.5302.967", "volume": "275", "author": "N. Rampino", "year": "1997", "unstructured": "Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., and Perucho, M. (1997). Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275, 967\u2013969.", "journal-title": "Science"}, {"key": "41_CR137", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1038/ncponc0538", "volume": "3", "author": "J. C. Reed", "year": "2006", "unstructured": "Reed, J. C. (2006). Drug insight: cancer therapy strategies based on restoration of endogenous cell death mechanisms. Nat Clin Pract Oncol 3, 388\u2013398.", "journal-title": "Nat Clin Pract Oncol"}, {"key": "41_CR138", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1016/j.ccr.2007.05.006", "volume": "12", "author": "M. S. Ricci", "year": "2007", "unstructured": "Ricci, M. S., Kim, S. H., Ogi, K., Plastaras, J. P., Ling, J., Wang, W., Jin, Z., Liu, Y. Y., Dicker, D. T., Chiao, P. J., et al. (2007). Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death. Cancer Cell 12, 66\u201380.", "journal-title": "Cancer Cell"}, {"key": "41_CR139", "doi-asserted-by": "publisher", "first-page": "430", "DOI": "10.1038/nrd1380", "volume": "3", "author": "J. N. Rich", "year": "2004", "unstructured": "Rich, J. N., and Bigner, D. D. (2004). Development of novel targeted therapies in the treatment of malignant glioma. Nat Rev Drug Discov 3, 430\u2013446.", "journal-title": "Nat Rev Drug Discov"}, {"key": "41_CR140", "doi-asserted-by": "publisher", "first-page": "4128", "DOI": "10.1038/sj.onc.1204534", "volume": "20", "author": "T. A. Rohn", "year": "2001", "unstructured": "Rohn, T. A., Wagenknecht, B., Roth, W., Naumann, U., Gulbins, E., Krammer, P. H., Walczak, H., and Weller, M. (2001). CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Oncogene 20, 4128\u20134137.", "journal-title": "Oncogene"}, {"key": "41_CR141", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1006/bbrc.1999.1693", "volume": "265", "author": "W. Roth", "year": "1999", "unstructured": "Roth, W., Isenmann, S., Naumann, U., Kugler, S., Bahr, M., Dichgans, J., Ashkenazi, A., and Weller, M. (1999). Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 265, 479\u2013483.", "journal-title": "Biochem Biophys Res Commun"}, {"key": "41_CR142", "doi-asserted-by": "publisher", "first-page": "6858", "DOI": "10.1158/0008-5472.CAN-04-1683", "volume": "64", "author": "R. Saito", "year": "2004", "unstructured": "Saito, R., Bringas, J. R., Panner, A., Tamas, M., Pieper, R. O., Berger, M. S., and Bankiewicz, K. S. (2004). Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res 64, 6858\u20136862.", "journal-title": "Cancer Res"}, {"key": "41_CR143", "doi-asserted-by": "publisher", "first-page": "10964", "DOI": "10.1073/pnas.96.20.10964", "volume": "96", "author": "G. S. Salvesen", "year": "1999", "unstructured": "Salvesen, G. S., and Dixit, V. M. (1999). Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A 96, 10964\u201310967.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "41_CR144", "doi-asserted-by": "publisher", "first-page": "401", "DOI": "10.1038/nrm830", "volume": "3", "author": "G. S. Salvesen", "year": "2002", "unstructured": "Salvesen, G. S., and Duckett, C. S. (2002). IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3, 401\u2013410.", "journal-title": "Nat Rev Mol Cell Biol"}, {"key": "41_CR145", "doi-asserted-by": "publisher", "first-page": "26953", "DOI": "10.1074/jbc.272.43.26953", "volume": "272", "author": "C. Scaffidi", "year": "1997", "unstructured": "Scaffidi, C., Medema, J. P., Krammer, P. H., and Peter, M. E. (1997). FLICE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-8/b. J Biol Chem 272, 26953\u201326958.", "journal-title": "J Biol Chem"}, {"key": "41_CR146", "doi-asserted-by": "publisher", "first-page": "1541", "DOI": "10.1074/jbc.274.3.1541", "volume": "274", "author": "C. Scaffidi", "year": "1999", "unstructured": "Scaffidi, C., Schmitz, I., Krammer, P. H., and Peter, M. E. (1999). The role of c-FLIP in modulation of CD95-induced apoptosis. J Biol Chem 274, 1541\u20131548.", "journal-title": "J Biol Chem"}, {"key": "41_CR147", "first-page": "1651", "volume": "51", "author": "J. H. Schiller", "year": "1991", "unstructured": "Schiller, J. H., Storer, B. E., Witt, P. L., Alberti, D., Tombes, M. B., Arzoomanian, R., Proctor, R. A., McCarthy, D., Brown, R. R., Voss, S. D., and et al. (1991). Biological and clinical effects of intravenous tumor necrosis factor-alpha administered three times weekly. Cancer Res 51, 1651\u20131658.", "journal-title": "Cancer Res"}, {"key": "41_CR148", "doi-asserted-by": "publisher", "first-page": "1433", "DOI": "10.1038/nm1202-797", "volume": "8", "author": "C. Schmaltz", "year": "2002", "unstructured": "Schmaltz, C., Alpdogan, O., Kappel, B. J., Muriglan, S. J., Rotolo, J. A., Ongchin, J., Willis, L. M., Greenberg, A. S., Eng, J. M., Crawford, J. M., et al. (2002). T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med 8, 1433\u20131437.", "journal-title": "Nat Med"}, {"key": "41_CR149", "doi-asserted-by": "publisher", "first-page": "329", "DOI": "10.1016/S0014-5793(97)01231-3", "volume": "416", "author": "P. Schneider", "year": "1997", "unstructured": "Schneider, P., Bodmer, J. L., Thome, M., Hofmann, K., Holler, N., and Tschopp, J. (1997a). Characterization of two receptors for TRAIL. FEBS Lett 416, 329\u2013334.", "journal-title": "FEBS Lett"}, {"key": "41_CR150", "doi-asserted-by": "publisher", "first-page": "831", "DOI": "10.1016/S1074-7613(00)80401-X", "volume": "7", "author": "P. Schneider", "year": "1997", "unstructured": "Schneider, P., Thome, M., Burns, K., Bodmer, J. L., Hofmann, K., Kataoka, T., Holler, N., and Tschopp, J. (1997b). TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 7, 831\u2013836.", "journal-title": "Immunity"}, {"key": "41_CR151", "doi-asserted-by": "publisher", "first-page": "19401", "DOI": "10.1074/jbc.M413962200", "volume": "280", "author": "D. A. Sharp", "year": "2005", "unstructured": "Sharp, D. A., Lawrence, D. A., and Ashkenazi, A. (2005). Selective Knockdown of the Long Variant of Cellular FLICE Inhibitory Protein Augments Death Receptor-mediated Caspase-8 Activation and Apoptosis. J Biol Chem 280, 19401\u201319409.", "journal-title": "J Biol Chem"}, {"key": "41_CR152", "doi-asserted-by": "publisher", "first-page": "4153", "DOI": "10.1038/sj.onc.1202763", "volume": "18", "author": "M. S. Sheikh", "year": "1999", "unstructured": "Sheikh, M. S., Huang, Y., Fernandez-Salas, E. A., El-Deiry, W. S., Friess, H., Amundson, S., Yin, J., Meltzer, S. J., Holbrook, N. J., and Fornace, A. J., Jr. (1999). The antiapoptotic decoy receptor TRID/TRAIL-R3 is a p53-regulated DNA damage-inducible gene that is overexpressed in primary tumors of the gastrointestinal tract. Oncogene 18, 4153\u20134159.", "journal-title": "Oncogene"}, {"key": "41_CR153", "doi-asserted-by": "publisher", "first-page": "818", "DOI": "10.1126/science.277.5327.818", "volume": "277", "author": "J. P. Sheridan", "year": "1997", "unstructured": "Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997). Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277, 818\u2013821.", "journal-title": "Science"}, {"key": "41_CR154", "doi-asserted-by": "publisher", "first-page": "5404", "DOI": "10.1128/MCB.25.13.5404-5416.2005", "volume": "25", "author": "S. Shetty", "year": "2005", "unstructured": "Shetty, S., Graham, B. A., Brown, J. G., Hu, X., Vegh-Yarema, N., Harding, G., Paul, J. T., and Gibson, S. B. (2005). Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1. Mol Cell Biol 25, 5404\u20135416.", "journal-title": "Mol Cell Biol"}, {"key": "41_CR155", "first-page": "4942", "volume": "61", "author": "M. S. Shin", "year": "2001", "unstructured": "Shin, M. S., Kim, H. S., Lee, S. H., Park, W. S., Kim, S. Y., Park, J. Y., Lee, J. H., Lee, S. K., Lee, S. N., Jung, S. S., et al. (2001). Mutations of tumor necrosis factor-related apoptosis-inducing ligand receptor 1 (TRAIL-R1) and receptor 2 (TRAIL-R2) genes in metastatic breast cancers. Cancer Res 61, 4942\u20134946.", "journal-title": "Cancer Res"}, {"key": "41_CR156", "doi-asserted-by": "publisher", "first-page": "7265", "DOI": "10.1038/sj.onc.1206933", "volume": "22", "author": "Z. H. Siddik", "year": "2003", "unstructured": "Siddik, Z. H. (2003). Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265\u20137279.", "journal-title": "Oncogene"}, {"key": "41_CR157", "first-page": "5390", "volume": "63", "author": "T. R. Singh", "year": "2003", "unstructured": "Singh, T. R., Shankar, S., Chen, X., Asim, M., and Srivastava, R. K. (2003). Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo. Cancer Res 63, 5390\u20135400.", "journal-title": "Cancer Res"}, {"key": "41_CR158", "doi-asserted-by": "publisher", "first-page": "67", "DOI": "10.1097/00002371-199201000-00008", "volume": "11", "author": "J. Skillings", "year": "1992", "unstructured": "Skillings, J., Wierzbicki, R., Eisenhauer, E., Venner, P., Letendre, F., Stewart, D., and Weinerman, B. (1992). A phase II study of recombinant tumor necrosis factor in renal cell carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group. J Immunother (1991) 11, 67\u201370.", "journal-title": "J Immunother (1991)"}, {"key": "41_CR159", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1016/S1074-7613(02)00502-2", "volume": "18", "author": "M. J. Smyth", "year": "2003", "unstructured": "Smyth, M. J., Takeda, K., Hayakawa, Y., Peschon, J. J., van den Brink, M. R., and Yagita, H. (2003). Nature's TRAIL--on a path to cancer immunotherapy. Immunity 18, 1\u20136.", "journal-title": "Immunity"}, {"key": "41_CR160", "first-page": "4255", "volume": "9", "author": "J. H. Song", "year": "2003", "unstructured": "Song, J. H., Song, D. K., Herlyn, M., Petruk, K. C., and Hao, C. (2003a). Cisplatin down-regulation of cellular Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory proteins to restore tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human melanoma cells. Clin Cancer Res 9, 4255\u20134266.", "journal-title": "Clin Cancer Res"}, {"key": "41_CR161", "doi-asserted-by": "publisher", "first-page": "539", "DOI": "10.1111/j.1750-3639.2003.tb00484.x", "volume": "13", "author": "J. H. Song", "year": "2003", "unstructured": "Song, J. H., Song, D. K., Pyrzynska, B., Petruk, K. C., Van Meir, E. G., and Hao, C. (2003b). TRAIL triggers apoptosis in malignant glioma cells through extrinsic and intrinsic pathways. Brain Pathol 13, 539\u2013553.", "journal-title": "Brain Pathol"}, {"key": "41_CR162", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1158/0008-5472.CAN-06-3016", "volume": "67", "author": "J. H. Song", "year": "2007", "unstructured": "Song, J. H., Tse, M. C. L., Bellail, A., Khuri, F. R., Phuphanich, S., Kneteman, N. M., and Hao, C. (2007). Lipid rafts and non-rafts mediate TRAIL-induced apoptotic and non-apoptotic signals in non-small cell lung carcinoma cells. Cancer Res 67, 1\u201310.", "journal-title": "Cancer Res"}, {"key": "41_CR163", "first-page": "815", "volume": "65", "author": "Y. H. Soung", "year": "2005", "unstructured": "Soung, Y. H., Lee, J. W., Kim, S. Y., Jang, J., Park, Y. G., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., and Lee, S. H. (2005). CASPASE-8 gene is inactivated by somatic mutations in gastric carcinomas. Cancer Res 65, 815\u2013821.", "journal-title": "Cancer Res"}, {"key": "41_CR164", "doi-asserted-by": "publisher", "first-page": "4520", "DOI": "10.1093/emboj/cdf441", "volume": "21", "author": "M. R. Sprick", "year": "2002", "unstructured": "Sprick, M. R., Rieser, E., Stahl, H., Grosse-Wilde, A., Weigand, M. A., and Walczak, H. (2002). Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8. Embo J 21, 4520\u20134530.", "journal-title": "Embo J"}, {"key": "41_CR165", "doi-asserted-by": "publisher", "first-page": "513", "DOI": "10.1016/0092-8674(95)90072-1", "volume": "81", "author": "B. Z. Stanger", "year": "1995", "unstructured": "Stanger, B. Z., Leder, P., Lee, T. H., Kim, E., and Seed, B. (1995). RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513\u2013523.", "journal-title": "Cell"}, {"key": "41_CR166", "doi-asserted-by": "publisher", "first-page": "1564", "DOI": "10.1038/sj.cdd.4401846", "volume": "13", "author": "L. P. Steele", "year": "2006", "unstructured": "Steele, L. P., Georgopoulos, N. T., Southgate, J., Selby, P. J., and Trejdosiewicz, L. K. (2006). Differential susceptibility to TRAIL of normal versus malignant human urothelial cells. Cell Death Differ 13, 1564\u20131576.", "journal-title": "Cell Death Differ"}, {"key": "41_CR167", "doi-asserted-by": "publisher", "first-page": "1169", "DOI": "10.1016/0092-8674(93)90326-L", "volume": "75", "author": "T. Suda", "year": "1993", "unstructured": "Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169\u20131178.", "journal-title": "Cell"}, {"key": "41_CR168", "doi-asserted-by": "publisher", "first-page": "214", "DOI": "10.1038/nm1356", "volume": "12", "author": "J. Taieb", "year": "2006", "unstructured": "Taieb, J., Chaput, N., Menard, C., Apetoh, L., Ullrich, E., Bonmort, M., Pequignot, M., Casares, N., Terme, M., Flament, C., et al. (2006). A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med 12, 214\u2013219.", "journal-title": "Nat Med"}, {"key": "41_CR169", "doi-asserted-by": "publisher", "first-page": "94", "DOI": "10.1038/83416", "volume": "7", "author": "K. Takeda", "year": "2001", "unstructured": "Takeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., and Okumura, K. (2001). Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7, 94\u2013100.", "journal-title": "Nat Med"}, {"key": "41_CR170", "doi-asserted-by": "publisher", "first-page": "161", "DOI": "10.1084/jem.20011171", "volume": "195", "author": "K. Takeda", "year": "2002", "unstructured": "Takeda, K., Smyth, M. J., Cretney, E., Hayakawa, Y., Kayagaki, N., Yagita, H., and Okumura, K. (2002). Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 195, 161\u2013169.", "journal-title": "J Exp Med"}, {"key": "41_CR171", "doi-asserted-by": "publisher", "first-page": "17", "DOI": "10.1016/j.drup.2008.02.001", "volume": "11", "author": "A. Thorburn", "year": "2008", "unstructured": "Thorburn, A., Behbakht, K., and Ford, H. (2008). TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them. Drug Resist Updat 11, 17\u201324.", "journal-title": "Drug Resist Updat"}, {"key": "41_CR172", "doi-asserted-by": "publisher", "first-page": "1390", "DOI": "10.1200/JCO.2006.08.8898", "volume": "25", "author": "A. W. Tolcher", "year": "2007", "unstructured": "Tolcher, A. W., Mita, M., Meropol, N. J., von Mehren, M., Patnaik, A., Padavic, K., Hill, M., Mays, T., McCoy, T., Fox, N. L., et al. (2007). Phase I pharmacokinetic and biologic correlative study of mapatumumab, a fully human monoclonal antibody with agonist activity to tumor necrosis factor-related apoptosis-inducing ligand receptor-1. J Clin Oncol 25, 1390\u20131395.", "journal-title": "J Clin Oncol"}, {"key": "41_CR173", "doi-asserted-by": "publisher", "first-page": "470", "DOI": "10.1126/science.3764421", "volume": "234", "author": "K. J. Tracey", "year": "1986", "unstructured": "Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., 3rd, Zentella, A., Albert, J. D., and et al. (1986). Shock and tissue injury induced by recombinant human cachectin. Science 234, 470\u2013474.", "journal-title": "Science"}, {"key": "41_CR174", "doi-asserted-by": "publisher", "first-page": "301", "DOI": "10.1126/science.2787530", "volume": "245", "author": "B. C. Trauth", "year": "1989", "unstructured": "Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., and Krammer, P. H. (1989). Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301\u2013305.", "journal-title": "Science"}, {"key": "41_CR175", "unstructured": "Trauzold, A., Siegmund, D., Schniewind, B., Sipos, B., Egberts, J., Zorenkov, D., Emme, D., Roder, C., Kalthoff, H., and Wajant, H. (2006). TRAIL promotes metastasis of human pancreatic ductal adenocarcinoma. Oncogene.", "DOI": "10.1038/sj.onc.1209719", "doi-asserted-by": "crossref"}, {"key": "41_CR176", "doi-asserted-by": "publisher", "first-page": "517", "DOI": "10.1016/j.ijrobp.2008.02.002", "volume": "71", "author": "H. Tsurushima", "year": "2008", "unstructured": "Tsurushima, H., Yuan, X., Dillehay, L. E., and Leong, K. W. (2008). Radiation-inducible caspase-8 gene therapy for malignant brain tumors. Int J Radiat Oncol Biol Phys 71, 517\u2013525.", "journal-title": "Int J Radiat Oncol Biol Phys"}, {"key": "41_CR177", "doi-asserted-by": "publisher", "first-page": "40599", "DOI": "10.1074/jbc.M509560200", "volume": "280", "author": "E. Varfolomeev", "year": "2005", "unstructured": "Varfolomeev, E., Maecker, H., Sharp, D., Lawrence, D., Renz, M., Vucic, D., and Ashkenazi, A. (2005). Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 280, 40599\u201340608.", "journal-title": "J Biol Chem"}, {"key": "41_CR178", "doi-asserted-by": "publisher", "first-page": "43", "DOI": "10.1016/S0092-8674(00)00009-X", "volume": "102", "author": "A. M. Verhagen", "year": "2000", "unstructured": "Verhagen, A. M., Ekert, P. G., Pakusch, M., Silke, J., Connolly, L. M., Reid, G. E., Moritz, R. L., Simpson, R. J., and Vaux, D. L. (2000). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43\u201353.", "journal-title": "Cell"}, {"key": "41_CR179", "doi-asserted-by": "publisher", "first-page": "789", "DOI": "10.1038/nm1087", "volume": "10", "author": "B. Vogelstein", "year": "2004", "unstructured": "Vogelstein, B., and Kinzler, K. W. (2004). Cancer genes and the pathways they control. Nat Med 10, 789\u2013799.", "journal-title": "Nat Med"}, {"key": "41_CR180", "doi-asserted-by": "publisher", "first-page": "370", "DOI": "10.1038/sj.cdd.4400503", "volume": "6", "author": "B. Wagenknecht", "year": "1999", "unstructured": "Wagenknecht, B., Glaser, T., Naumann, U., Kugler, S., Isenmann, S., Bahr, M., Korneluk, R., Liston, P., and Weller, M. (1999). Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 6, 370\u2013376.", "journal-title": "Cell Death Differ"}, {"key": "41_CR181", "doi-asserted-by": "publisher", "first-page": "5386", "DOI": "10.1093/emboj/16.17.5386", "volume": "16", "author": "H. Walczak", "year": "1997", "unstructured": "Walczak, H., Degli-Esposti, M. A., Johnson, R. S., Smolak, P. J., Waugh, J. Y., Boiani, N., Timour, M. S., Gerhart, M. J., Schooley, K. A., Smith, C. A., et al. (1997). TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. Embo J 16, 5386\u20135397.", "journal-title": "Embo J"}, {"key": "41_CR182", "doi-asserted-by": "publisher", "first-page": "157", "DOI": "10.1038/5517", "volume": "5", "author": "H. Walczak", "year": "1999", "unstructured": "Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5, 157\u2013163.", "journal-title": "Nat Med"}, {"key": "41_CR183", "doi-asserted-by": "publisher", "first-page": "343", "DOI": "10.1016/0092-8674(94)90303-4", "volume": "78", "author": "N. P. Walker", "year": "1994", "unstructured": "Walker, N. P., Talanian, R. V., Brady, K. D., Dang, L. C., Bump, N. J., Ferenz, C. R., Franklin, S., Ghayur, T., Hackett, M. C., Hammill, L. D., and et al. (1994). Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer. Cell 78, 343\u2013352.", "journal-title": "Cell"}, {"key": "41_CR184", "doi-asserted-by": "publisher", "first-page": "13884", "DOI": "10.1073/pnas.241358198", "volume": "98", "author": "J. Wang", "year": "2001", "unstructured": "Wang, J., Chun, H. J., Wong, W., Spencer, D. M., and Lenardo, M. J. (2001). Caspase-10 is an initiator caspase in death receptor signaling. Proc Natl Acad Sci U S A 98, 13884\u201313888.", "journal-title": "Proc Natl Acad Sci U S A"}, {"key": "41_CR185", "first-page": "2060", "volume": "14", "author": "M. C. Wei", "year": "2000", "unstructured": "Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., and Korsmeyer, S. J. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14, 2060\u20132071.", "journal-title": "Genes Dev"}, {"key": "41_CR186", "doi-asserted-by": "publisher", "first-page": "718", "DOI": "10.1038/sj.cdd.4402301", "volume": "15", "author": "L. Weinmann", "year": "2008", "unstructured": "Weinmann, L., Wischhusen, J., Demma, M. J., Naumann, U., Roth, P., Dasmahapatra, B., and Weller, M. (2008). A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis. Cell Death Differ 15, 718\u2013729.", "journal-title": "Cell Death Differ"}, {"key": "41_CR187", "doi-asserted-by": "publisher", "first-page": "673", "DOI": "10.1016/1074-7613(95)90057-8", "volume": "3", "author": "S. R. Wiley", "year": "1995", "unstructured": "Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., and et al. (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3, 673\u2013682.", "journal-title": "Immunity"}, {"key": "41_CR188", "doi-asserted-by": "publisher", "first-page": "270", "DOI": "10.1038/370270a0", "volume": "370", "author": "K. P. Wilson", "year": "1994", "unstructured": "Wilson, K. P., Black, J. A., Thomson, J. A., Kim, E. E., Griffith, J. P., Navia, M. A., Murcko, M. A., Chambers, S. P., Aldape, R. A., Raybuck, S. A., and et al. (1994). Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370, 270\u2013275.", "journal-title": "Nature"}, {"key": "41_CR189", "doi-asserted-by": "publisher", "first-page": "8783", "DOI": "10.1158/0008-5472.CAN-07-0357", "volume": "67", "author": "M. E. Wohlfahrt", "year": "2007", "unstructured": "Wohlfahrt, M. E., Beard, B. C., Lieber, A., and Kiem, H. P. (2007). A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models. Cancer Res 67, 8783\u20138790.", "journal-title": "Cancer Res"}, {"key": "41_CR190", "doi-asserted-by": "publisher", "first-page": "141", "DOI": "10.1038/ng1097-141", "volume": "17", "author": "G. S. Wu", "year": "1997", "unstructured": "Wu, G. S., Burns, T. F., McDonald, E. R., 3rd, Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D. D., Zhou, J. Y., Muschel, R., et al. (1997). KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene. Nat Genet 17, 141\u2013143.", "journal-title": "Nat Genet"}, {"key": "41_CR191", "doi-asserted-by": "publisher", "first-page": "25020", "DOI": "10.1074/jbc.M202946200", "volume": "277", "author": "C. Xiao", "year": "2002", "unstructured": "Xiao, C., Yang, B. F., Asadi, N., Beguinot, F., and Hao, C. (2002). Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J Biol Chem 277, 25020\u201325025.", "journal-title": "J Biol Chem"}, {"key": "41_CR192", "doi-asserted-by": "publisher", "first-page": "1060", "DOI": "10.1093/annonc/mdn015", "volume": "19", "author": "A. Yada", "year": "2008", "unstructured": "Yada, A., Yazawa, M., Ishida, S., Yoshida, H., Ichikawa, K., Kurakata, S., and Fujiwara, K. (2008). A novel humanized anti-human death receptor 5 antibody CS-1008 induces apoptosis in tumor cells without toxicity in hepatocytes. Ann Oncol 19, 1060\u20131067.", "journal-title": "Ann Oncol"}, {"key": "41_CR193", "doi-asserted-by": "publisher", "first-page": "7043", "DOI": "10.1074/jbc.M211278200", "volume": "278", "author": "B. F. Yang", "year": "2003", "unstructured": "Yang, B. F., Xiao, C., Roa, W. H., Krammer, P. H., and Hao, C. (2003). Calcium/Calmodulin-dependent Protein Kinase II Regulation of c-FLIP Expression and Phosphorylation in Modulation of Fas-mediated Signaling in Malignant Glioma Cells. J Biol Chem 278, 7043\u20137050.", "journal-title": "J Biol Chem"}, {"key": "41_CR194", "doi-asserted-by": "publisher", "first-page": "319", "DOI": "10.1016/S1097-2765(00)80032-5", "volume": "1", "author": "X. Yang", "year": "1998", "unstructured": "Yang, X., Chang, H. Y., and Baltimore, D. (1998). Autoproteolytic activation of pro-caspases by oligomerization. Mol Cell 1, 319\u2013325.", "journal-title": "Mol Cell"}, {"key": "41_CR195", "doi-asserted-by": "publisher", "first-page": "7570", "DOI": "10.1158/0008-5472.CAN-04-1238", "volume": "64", "author": "W. Zou", "year": "2004", "unstructured": "Zou, W., Liu, X., Yue, P., Zhou, Z., Sporn, M. B., Lotan, R., Khuri, F. R., and Sun, S. Y. (2004). c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate in human lung cancer cells. Cancer Res 64, 7570\u20137578.", "journal-title": "Cancer Res"}], "container-title": ["CNS Cancer"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/978-1-60327-553-8_41", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 27]], "date-time": "2019-04-27T10:07:08Z", "timestamp": 1556359628000}, "score": 30.474182, "issued": {"date-parts": [[2009]]}, "ISBN": ["9781603275521", "9781603275538"], "references-count": 195, "URL": "http://dx.doi.org/10.1007/978-1-60327-553-8_41", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 20]], "date-time": "2019-12-20T19:24:52Z", "timestamp": 1576869892165}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "4", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2009, 2, 15]]}, "DOI": "10.1158/1078-0432.ccr-08-0144", "type": "journal-article", "created": {"date-parts": [[2009, 2, 19]], "date-time": "2009-02-19T11:04:43Z", "timestamp": 1235041483000}, "page": "1126-1132", "source": "Crossref", "is-referenced-by-count": 546, "title": ["Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy"], "prefix": "10.1158", "volume": "15", "author": [{"given": "M. H.", "family": "Kang", "sequence": "first", "affiliation": []}, {"given": "C. P.", "family": "Reynolds", "sequence": "additional", "affiliation": []}], "member": "1086", "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-08-0144", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T05:03:11Z", "timestamp": 1482469391000}, "score": 28.937004, "issued": {"date-parts": [[2009, 2, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2009, 2, 15]]}, "issue": "4"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-08-0144", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T05:24:18Z", "timestamp": 1574486658915}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2012, 7, 1]], "date-time": "2012-07-01T00:00:00Z", "timestamp": 1341100800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["European Journal of Cancer"], "published-print": {"date-parts": [[2012, 7]]}, "DOI": "10.1016/s0959-8049(12)71104-8", "type": "journal-article", "created": {"date-parts": [[2012, 7, 6]], "date-time": "2012-07-06T17:08:46Z", "timestamp": 1341594526000}, "page": "S102-S103", "source": "Crossref", "is-referenced-by-count": 0, "title": ["422 Investigation of the Apoptotic Pathways Activated by Equol and Tamoxifen in MCF-7 Breast Cancer Cells"], "prefix": "10.1016", "volume": "48", "author": [{"given": "C.", "family": "Charalambous", "sequence": "first", "affiliation": []}, {"given": "A.I.", "family": "Constantinou", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["European Journal of Cancer"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0959804912711048?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0959804912711048?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 11, 22]], "date-time": "2018-11-22T08:57:30Z", "timestamp": 1542877050000}, "score": 27.28415, "issued": {"date-parts": [[2012, 7]]}, "references-count": 0, "alternative-id": ["S0959804912711048"], "URL": "http://dx.doi.org/10.1016/s0959-8049(12)71104-8", "ISSN": ["0959-8049"], "issn-type": [{"value": "0959-8049", "type": "print"}]}, {"institution": {"name": "West Virginia University Libraries", "place": ["-"], "department": ["Biochemistry"], "acronym": ["wvul"]}, "indexed": {"date-parts": [[2019, 12, 5]], "date-time": "2019-12-05T05:40:34Z", "timestamp": 1575524434398}, "reference-count": 0, "publisher": "West Virginia University Libraries", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.33915/etd.5905", "type": "dissertation", "created": {"date-parts": [[2019, 10, 3]], "date-time": "2019-10-03T13:40:31Z", "timestamp": 1570110031000}, "approved": {"date-parts": [[2017, 1, 1]]}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Dual Targeting of the Mesenchymal and Amoeboid Pathways: A Viable Therapy against Metastatic Breast Cancer"], "prefix": "10.33915", "author": [{"given": "Brandon C.", "family": "Jones", "sequence": "first", "affiliation": []}], "member": "19638", "deposited": {"date-parts": [[2019, 10, 23]], "date-time": "2019-10-23T13:57:25Z", "timestamp": 1571839045000}, "score": 24.250982, "degree": ["PhD"], "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.33915/etd.5905"}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T00:39:32Z", "timestamp": 1575419972238}, "reference-count": 79, "publisher": "Wiley", "issue": "6", "license": [{"URL": "http://doi.wiley.com/10.1002/tdm_license_1.1", "start": {"date-parts": [[2019, 4, 9]], "date-time": "2019-04-09T00:00:00Z", "timestamp": 1554768000000}, "delay-in-days": 0, "content-version": "tdm"}, {"URL": "http://onlinelibrary.wiley.com/termsAndConditions#vor", "start": {"date-parts": [[2019, 4, 9]], "date-time": "2019-04-09T00:00:00Z", "timestamp": 1554768000000}, "delay-in-days": 0, "content-version": "vor"}], "funder": [{"DOI": "10.13039/501100000015", "name": "Canadian Cancer Society Research Institute", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/501100000024", "name": "Canadian Institutes of Health Research", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/100012118", "name": "Ontario Institute for Cancer Research", "doi-asserted-by": "publisher", "award": []}, {"DOI": "10.13039/501100002655", "name": "Terry Fox Foundation", "doi-asserted-by": "publisher", "award": []}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Stem Cells"], "published-print": {"date-parts": [[2019, 6]]}, "DOI": "10.1002/stem.3004", "type": "journal-article", "created": {"date-parts": [[2019, 3, 16]], "date-time": "2019-03-16T04:36:59Z", "timestamp": 1552711019000}, "page": "716-723", "source": "Crossref", "is-referenced-by-count": 2, "title": ["Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses"], "prefix": "10.1002", "volume": "37", "author": [{"given": "Mathieu J.F.", "family": "Crupi", "sequence": "first", "affiliation": [{"name": "Centre for Innovative Cancer Research; Ottawa Hospital Research Institute; Ottawa Ontario Canada"}, {"name": "Department of Biochemistry, Microbiology, and Immunology; University of Ottawa; Ottawa Ontario Canada"}]}, {"given": "John C.", "family": "Bell", "sequence": "additional", "affiliation": [{"name": "Centre for Innovative Cancer Research; Ottawa Hospital Research Institute; Ottawa Ontario Canada"}, {"name": "Department of Biochemistry, Microbiology, and Immunology; University of Ottawa; Ottawa Ontario Canada"}]}, {"ORCID": "http://orcid.org/0000-0002-2692-3650", "authenticated-orcid": false, "given": "Ragunath", "family": "Singaravelu", "sequence": "additional", "affiliation": [{"name": "Centre for Innovative Cancer Research; Ottawa Hospital Research Institute; Ottawa Ontario Canada"}, {"name": "Department of Biochemistry, Microbiology, and Immunology; University of Ottawa; Ottawa Ontario Canada"}]}], "member": "311", "published-online": {"date-parts": [[2019, 4, 9]]}, "reference": [{"key": "10.1002/stem.3004-BIB0001|stem3004-cit-0001", "doi-asserted-by": "crossref", "first-page": "9339", "DOI": "10.1158/0008-5472.CAN-06-3126", "article-title": "Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells", "volume": "66", "author": "Clarke", "year": "2006", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0002|stem3004-cit-0002", "doi-asserted-by": "crossref", "first-page": "821", "DOI": "10.1038/77558", "article-title": "Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus", "volume": "6", "author": "Stojdl", "year": "2000", "journal-title": "Nat Med"}, {"key": "10.1002/stem.3004-BIB0003|stem3004-cit-0003", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1038/nri1604", "article-title": "Mechanisms of type-I- and type-II-interferon-mediated signalling", "volume": "5", "author": "Platanias", "year": "2005", "journal-title": "Nat Rev Immunol"}, {"key": "10.1002/stem.3004-BIB0004|stem3004-cit-0004", "doi-asserted-by": "crossref", "first-page": "5928", "DOI": "10.1128/JVI.02587-08", "article-title": "Induction of alpha/beta interferon by myxoma virus is selectively abrogated when primary mouse embryo fibroblasts become immortalized", "volume": "83", "author": "Wang", "year": "2009", "journal-title": "J Virol"}, {"key": "10.1002/stem.3004-BIB0005|stem3004-cit-0005", "doi-asserted-by": "crossref", "first-page": "4118", "DOI": "10.1038/sj.onc.1206594", "article-title": "Epigenetic silencing of multiple interferon pathway genes after cellular immortalization", "volume": "22", "author": "Kulaeva", "year": "2003", "journal-title": "Oncogene"}, {"key": "10.1002/stem.3004-BIB0006|stem3004-cit-0006", "doi-asserted-by": "crossref", "first-page": "651", "DOI": "10.1002/gcc.22468", "article-title": "Mutation patterns in genes encoding interferon signaling and antigen presentation: A pan-cancer survey with implications for the use of immune checkpoint inhibitors", "volume": "56", "author": "Budczies", "year": "2017", "journal-title": "Genes Chromosomes Cancer"}, {"key": "10.1002/stem.3004-BIB0007|stem3004-cit-0007", "doi-asserted-by": "crossref", "first-page": "282", "DOI": "10.1016/j.celrep.2015.12.029", "article-title": "Deregulation of STING signaling in colorectal carcinoma constrains DNA damage responses and correlates with tumorigenesis", "volume": "14", "author": "Xia", "year": "2016", "journal-title": "Cell Rep"}, {"key": "10.1002/stem.3004-BIB0008|stem3004-cit-0008", "doi-asserted-by": "crossref", "first-page": "530", "DOI": "10.1038/nm.3848", "article-title": "Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity", "volume": "21", "author": "Ilkow", "year": "2015", "journal-title": "Nat Med"}, {"key": "10.1002/stem.3004-BIB0009|stem3004-cit-0009", "doi-asserted-by": "crossref", "first-page": "210", "DOI": "10.1016/j.ccell.2015.06.009", "article-title": "VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection", "volume": "28", "author": "Arulanandam", "year": "2015", "journal-title": "Cancer Cell"}, {"key": "10.1002/stem.3004-BIB0010|stem3004-cit-0010", "doi-asserted-by": "crossref", "first-page": "e109760", "DOI": "10.1371/journal.pone.0109760", "article-title": "Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis", "volume": "9", "author": "Linsley", "year": "2014", "journal-title": "PLoS One"}, {"key": "10.1002/stem.3004-BIB0011|stem3004-cit-0011", "doi-asserted-by": "crossref", "first-page": "405", "DOI": "10.1038/nri3845", "article-title": "Type I interferons in anticancer immunity", "volume": "15", "author": "Zitvogel", "year": "2015", "journal-title": "Nat Rev Immunol"}, {"key": "10.1002/stem.3004-BIB0012|stem3004-cit-0012", "doi-asserted-by": "crossref", "first-page": "1989", "DOI": "10.1084/jem.20101158", "article-title": "Type I interferon is selectively required by dendritic cells for immune rejection of tumors", "volume": "208", "author": "Diamond", "year": "2011", "journal-title": "J Exp Med"}, {"key": "10.1002/stem.3004-BIB0013|stem3004-cit-0013", "doi-asserted-by": "crossref", "first-page": "2005", "DOI": "10.1084/jem.20101159", "article-title": "Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells", "volume": "208", "author": "Fuertes", "year": "2011", "journal-title": "J Exp Med"}, {"key": "10.1002/stem.3004-BIB0014|stem3004-cit-0014", "doi-asserted-by": "crossref", "first-page": "226ra32", "DOI": "10.1126/scitranslmed.3008095", "article-title": "Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy", "volume": "6", "author": "Zamarin", "year": "2014", "journal-title": "Sci Transl Med"}, {"key": "10.1002/stem.3004-BIB0015|stem3004-cit-0015", "doi-asserted-by": "crossref", "first-page": "eaal1713", "DOI": "10.1126/sciimmunol.aal1713", "article-title": "Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells", "volume": "2", "author": "Dai", "year": "2017", "journal-title": "Sci Immunol"}, {"key": "10.1002/stem.3004-BIB0016|stem3004-cit-0016", "doi-asserted-by": "crossref", "first-page": "124", "DOI": "10.3390/cancers10040124", "article-title": "Oncolytic virotherapy versus cancer stem cells: A review of approaches and mechanisms", "volume": "10", "author": "Chaurasiya", "year": "2018", "journal-title": "Cancers"}, {"key": "10.1002/stem.3004-BIB0017|stem3004-cit-0017", "doi-asserted-by": "crossref", "first-page": "251", "DOI": "10.1038/mt.2009.283", "article-title": "Intelligent design: Combination therapy with oncolytic viruses", "volume": "18", "author": "Ottolino-Perry", "year": "2010", "journal-title": "Mol Ther"}, {"key": "10.1002/stem.3004-BIB0018|stem3004-cit-0018", "doi-asserted-by": "crossref", "first-page": "13792", "DOI": "10.1073/pnas.1713728114", "article-title": "Interferon-beta represses cancer stem cell properties in triple-negative breast cancer", "volume": "114", "author": "Doherty", "year": "2017", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "10.1002/stem.3004-BIB0019|stem3004-cit-0019", "doi-asserted-by": "crossref", "first-page": "658", "DOI": "10.1158/2326-6066.CIR-17-0675", "article-title": "Disruption of IFN-I signaling promotes HER2/Neu tumor progression and breast cancer stem cells", "volume": "6", "author": "Castiello", "year": "2018", "journal-title": "Cancer Immunol Res"}, {"key": "10.1002/stem.3004-BIB0020|stem3004-cit-0020", "first-page": "3363", "article-title": "Zika virus selectively kills aggressive human embryonal CNS tumor cells in vitro and in vivo", "volume": "78", "author": "Kaid", "year": "2018", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0021|stem3004-cit-0021", "doi-asserted-by": "crossref", "first-page": "2843", "DOI": "10.1084/jem.20171093", "article-title": "Zika virus has oncolytic activity against glioblastoma stem cells", "volume": "214", "author": "Zhu", "year": "2017", "journal-title": "J Exp Med"}, {"key": "10.1002/stem.3004-BIB0022|stem3004-cit-0022", "doi-asserted-by": "crossref", "first-page": "285", "DOI": "10.5483/BMBRep.2017.50.6.039", "article-title": "Cancer stem cell surface markers on normal stem cells", "volume": "50", "author": "Kim", "year": "2017", "journal-title": "BMB Rep"}, {"key": "10.1002/stem.3004-BIB0023|stem3004-cit-0023", "doi-asserted-by": "crossref", "first-page": "865", "DOI": "10.1158/0008-5472.CAN-12-2221", "article-title": "Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus", "volume": "73", "author": "Bach", "year": "2013", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0024|stem3004-cit-0024", "doi-asserted-by": "crossref", "first-page": "76044", "DOI": "10.18632/oncotarget.18340", "article-title": "CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer", "volume": "8", "author": "Sato-Dahlman", "year": "2017", "journal-title": "Oncotarget"}, {"key": "10.1002/stem.3004-BIB0025|stem3004-cit-0025", "doi-asserted-by": "crossref", "first-page": "479", "DOI": "10.1038/gt.2016.17", "article-title": "Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread", "volume": "23", "author": "Shibata", "year": "2016", "journal-title": "Gene Ther"}, {"key": "10.1002/stem.3004-BIB0026|stem3004-cit-0026", "doi-asserted-by": "crossref", "first-page": "16003", "DOI": "10.1038/mto.2016.3", "article-title": "Enhanced lysis by bispecific oncolytic measles viruses simultaneously using HER2/neu or EpCAM as target receptors", "volume": "3", "author": "Hanauer", "year": "2016", "journal-title": "Mol Ther Oncol"}, {"key": "10.1002/stem.3004-BIB0027|stem3004-cit-0027", "doi-asserted-by": "crossref", "first-page": "1154", "DOI": "10.1002/stem.2835", "article-title": "A novel oncolytic herpes capable of cell-specific transcriptional targeting of CD133\u00b1 cancer cells induces significant tumor regression", "volume": "36", "author": "Terai", "year": "2018", "journal-title": "Stem Cells"}, {"key": "10.1002/stem.3004-BIB0028|stem3004-cit-0028", "doi-asserted-by": "crossref", "first-page": "1414", "DOI": "10.1016/j.ymthe.2018.04.001", "article-title": "Oncolytic virus combination therapy: Killing one bird with two stones", "volume": "26", "author": "Martin", "year": "2018", "journal-title": "Mol Ther"}, {"key": "10.1002/stem.3004-BIB0029|stem3004-cit-0029", "doi-asserted-by": "crossref", "first-page": "256", "DOI": "10.1038/nature14897", "article-title": "Distinct EMT programs control normal mammary stem cells and tumour-initiating cells", "volume": "525", "author": "Ye", "year": "2015", "journal-title": "Nature"}, {"key": "10.1002/stem.3004-BIB0030|stem3004-cit-0030", "doi-asserted-by": "crossref", "first-page": "3571", "DOI": "10.1158/1078-0432.CCR-15-2665", "article-title": "CD44+ cells in head and neck squamous cell carcinoma suppress T-cell-mediated immunity by selective constitutive and inducible expression of PD-L1", "volume": "22", "author": "Lee", "year": "2016", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/stem.3004-BIB0031|stem3004-cit-0031", "doi-asserted-by": "crossref", "first-page": "1908", "DOI": "10.1038/s41467-018-04313-6", "article-title": "STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion", "volume": "9", "author": "Hsu", "year": "2018", "journal-title": "Nat Commun"}, {"key": "10.1002/stem.3004-BIB0032|stem3004-cit-0032", "doi-asserted-by": "crossref", "first-page": "409", "DOI": "10.1038/s41598-017-18762-4", "article-title": "Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism", "volume": "8", "author": "Kim", "year": "2018", "journal-title": "Sci Rep"}, {"key": "10.1002/stem.3004-BIB0033|stem3004-cit-0033", "doi-asserted-by": "crossref", "first-page": "362", "DOI": "10.1038/srep00362", "article-title": "Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells", "volume": "2", "author": "Song", "year": "2012", "journal-title": "Sci Rep"}, {"key": "10.1002/stem.3004-BIB0034|stem3004-cit-0034", "doi-asserted-by": "crossref", "first-page": "606", "DOI": "10.1016/j.molcel.2018.07.030", "article-title": "Metformin promotes antitumor immunity via endoplasmic-reticulum-associated degradation of PD-L1", "volume": "71", "author": "Cha", "year": "2018", "journal-title": "Mol Cell"}, {"key": "10.1002/stem.3004-BIB0035|stem3004-cit-0035", "doi-asserted-by": "crossref", "first-page": "590", "DOI": "10.1016/j.ccr.2014.03.033", "article-title": "Loss of Lkb1 and Pten leads to lung squamous cell carcinoma with elevated PD-L1 expression", "volume": "25", "author": "Xu", "year": "2014", "journal-title": "Cancer Cell"}, {"key": "10.1002/stem.3004-BIB0036|stem3004-cit-0036", "doi-asserted-by": "crossref", "first-page": "233", "DOI": "10.3389/fonc.2016.00233", "article-title": "Combination approaches with immune-checkpoint blockade in cancer therapy", "volume": "6", "author": "Swart", "year": "2016", "journal-title": "Front Oncol"}, {"key": "10.1002/stem.3004-BIB0037|stem3004-cit-0037", "doi-asserted-by": "crossref", "first-page": "2455", "DOI": "10.1056/NEJMoa1200694", "article-title": "Safety and activity of anti-PD-L1 antibody in patients with advanced cancer", "volume": "366", "author": "Brahmer", "year": "2012", "journal-title": "New Engl J Med"}, {"key": "10.1002/stem.3004-BIB0038|stem3004-cit-0038", "doi-asserted-by": "crossref", "first-page": "2443", "DOI": "10.1056/NEJMoa1200690", "article-title": "Safety, activity, and immune correlates of anti-PD-1 antibody in cancer", "volume": "366", "author": "Topalian", "year": "2012", "journal-title": "New Engl J Med"}, {"key": "10.1002/stem.3004-BIB0039|stem3004-cit-0039", "doi-asserted-by": "crossref", "first-page": "eaan4488", "DOI": "10.1126/scitranslmed.aan4488", "article-title": "Eradication of spontaneous malignancy by local immunotherapy", "volume": "10", "author": "Sagiv-Barfi", "year": "2018", "journal-title": "Sci Transl Med"}, {"key": "10.1002/stem.3004-BIB0040|stem3004-cit-0040", "doi-asserted-by": "crossref", "first-page": "450", "DOI": "10.1016/j.ccell.2015.03.001", "article-title": "Immune checkpoint blockade: A common denominator approach to cancer therapy", "volume": "27", "author": "Topalian", "year": "2015", "journal-title": "Cancer Cell"}, {"key": "10.1002/stem.3004-BIB0041|stem3004-cit-0041", "doi-asserted-by": "crossref", "first-page": "2952", "DOI": "10.1158/0008-5472.CAN-16-1638", "article-title": "Tumor-localized secretion of soluble PD1 enhances oncolytic virotherapy", "volume": "77", "author": "Bartee", "year": "2017", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0042|stem3004-cit-0042", "doi-asserted-by": "crossref", "first-page": "2006", "DOI": "10.1056/NEJMoa1414428", "article-title": "Nivolumab and ipilimumab versus ipilimumab in untreated melanoma", "volume": "372", "author": "Postow", "year": "2015", "journal-title": "New Engl J Med"}, {"key": "10.1002/stem.3004-BIB0043|stem3004-cit-0043", "doi-asserted-by": "crossref", "first-page": "2521", "DOI": "10.1056/NEJMoa1503093", "article-title": "Pembrolizumab versus Ipilimumab in advanced melanoma", "volume": "372", "author": "Robert", "year": "2015", "journal-title": "New Engl J Med"}, {"key": "10.1002/stem.3004-BIB0044|stem3004-cit-0044", "doi-asserted-by": "crossref", "first-page": "1020", "DOI": "10.1200/JCO.2013.53.0105", "article-title": "Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab", "volume": "32", "author": "Topalian", "year": "2014", "journal-title": "J Clin Oncol"}, {"key": "10.1002/stem.3004-BIB0045|stem3004-cit-0045", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1016/S1470-2045(15)70076-8", "article-title": "Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): A randomised, controlled, open-label, phase 3 trial", "volume": "16", "author": "Weber", "year": "2015", "journal-title": "Lancet Oncol"}, {"key": "10.1002/stem.3004-BIB0046|stem3004-cit-0046", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.1016/S0140-6736(14)60958-2", "article-title": "Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: A randomised dose-comparison cohort of a phase 1 trial", "volume": "384", "author": "Robert", "year": "2014", "journal-title": "Lancet"}, {"key": "10.1002/stem.3004-BIB0047|stem3004-cit-0047", "doi-asserted-by": "crossref", "first-page": "1560", "DOI": "10.1038/bjc.2013.117", "article-title": "Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer", "volume": "108", "author": "Quezada", "year": "2013", "journal-title": "Br J Cancer"}, {"key": "10.1002/stem.3004-BIB0048|stem3004-cit-0048", "doi-asserted-by": "crossref", "first-page": "1949", "DOI": "10.1038/mt.2014.160", "article-title": "CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy", "volume": "22", "author": "Engeland", "year": "2014", "journal-title": "Mol Ther"}, {"key": "10.1002/stem.3004-BIB0049|stem3004-cit-0049", "doi-asserted-by": "crossref", "first-page": "eaao1641", "DOI": "10.1126/scitranslmed.aao1641", "article-title": "Neoadjuvant oncolytic virotherapy before surgery sensitizes triple-negative breast cancer to immune checkpoint therapy", "volume": "10", "author": "Bourgeois-Daigneault", "year": "2018", "journal-title": "Sci Transl Med"}, {"key": "10.1002/stem.3004-BIB0050|stem3004-cit-0050", "doi-asserted-by": "crossref", "first-page": "1109", "DOI": "10.1016/j.cell.2017.08.027", "article-title": "Oncolytic virotherapy promotes intratumoral T cell infiltration and improves anti-PD-1 immunotherapy", "volume": "170", "author": "Ribas", "year": "2017", "journal-title": "Cell"}, {"key": "10.1002/stem.3004-BIB0051|stem3004-cit-0051", "doi-asserted-by": "crossref", "first-page": "eaam7577", "DOI": "10.1126/scitranslmed.aam7577", "article-title": "Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade", "volume": "10", "author": "Samson", "year": "2018", "journal-title": "Sci Transl Med"}, {"key": "10.1002/stem.3004-BIB0052|stem3004-cit-0052", "doi-asserted-by": "crossref", "first-page": "988", "DOI": "10.1038/gt.2011.176", "article-title": "Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4", "volume": "19", "author": "Dias", "year": "2012", "journal-title": "Gene Ther"}, {"key": "10.1002/stem.3004-BIB0053|stem3004-cit-0053", "doi-asserted-by": "crossref", "first-page": "e1220467", "DOI": "10.1080/2162402X.2016.1220467", "article-title": "Vectorization in an oncolytic vaccinia virus of an antibody, a Fab and a scFv against programmed cell death-1 (PD-1) allows their intratumoral delivery and an improved tumor-growth inhibition", "volume": "5", "author": "Kleinpeter", "year": "2016", "journal-title": "Oncoimmunology"}, {"key": "10.1002/stem.3004-BIB0054|stem3004-cit-0054", "doi-asserted-by": "crossref", "first-page": "1", "DOI": "10.1016/j.celrep.2017.12.025", "article-title": "A recombinant antibody-expressing influenza virus delays tumor growth in a mouse model", "volume": "22", "author": "Hamilton", "year": "2018", "journal-title": "Cell Rep"}, {"key": "10.1002/stem.3004-BIB0055|stem3004-cit-0055", "doi-asserted-by": "crossref", "first-page": "e0187314", "DOI": "10.1371/journal.pone.0187314", "article-title": "Hypoxia and hypoxia-inducible factor (HIF) downregulate antigen-presenting MHC class I molecules limiting tumor cell recognition by T cells", "volume": "12", "author": "Sethumadhavan", "year": "2017", "journal-title": "PLoS One"}, {"key": "10.1002/stem.3004-BIB0056|stem3004-cit-0056", "doi-asserted-by": "crossref", "first-page": "974", "DOI": "10.1126/science.1158545", "article-title": "Tumor regression in cancer patients by very low doses of a T cell-engaging antibody", "volume": "321", "author": "Bargou", "year": "2008", "journal-title": "Science"}, {"key": "10.1002/stem.3004-BIB0057|stem3004-cit-0057", "doi-asserted-by": "crossref", "first-page": "4035", "DOI": "10.1158/1078-0432.CCR-15-0612", "article-title": "FDA approval: Blinatumomab", "volume": "21", "author": "Przepiorka", "year": "2015", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/stem.3004-BIB0058|stem3004-cit-0058", "doi-asserted-by": "crossref", "first-page": "1700187", "DOI": "10.1002/mabi.201700187", "article-title": "Solid tumor immunotherapy with T cell engager-armed oncolytic viruses", "volume": "18", "author": "Scott", "year": "2018", "journal-title": "Macromol Biosci"}, {"key": "10.1002/stem.3004-BIB0059|stem3004-cit-0059", "doi-asserted-by": "crossref", "first-page": "2128", "DOI": "10.1158/1078-0432.CCR-17-2651", "article-title": "Targeted BiTE expression by an oncolytic vector augments therapeutic efficacy against solid tumors", "volume": "24", "author": "Speck", "year": "2018", "journal-title": "Clin Cancer Res"}, {"key": "10.1002/stem.3004-BIB0060|stem3004-cit-0060", "doi-asserted-by": "crossref", "first-page": "2052", "DOI": "10.1158/0008-5472.CAN-16-1708", "article-title": "Oncolytic adenoviral delivery of an EGFR-targeting T-cell engager improves antitumor efficacy", "volume": "77", "author": "Fajardo", "year": "2017", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0061|stem3004-cit-0061", "doi-asserted-by": "crossref", "first-page": "1067", "DOI": "10.15252/emmm.201707567", "article-title": "Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies", "volume": "9", "author": "Freedman", "year": "2017", "journal-title": "EMBO Mol Med"}, {"key": "10.1002/stem.3004-BIB0062|stem3004-cit-0062", "doi-asserted-by": "crossref", "first-page": "102", "DOI": "10.1038/mt.2013.240", "article-title": "T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy", "volume": "22", "author": "Yu", "year": "2014", "journal-title": "Mol Ther"}, {"key": "10.1002/stem.3004-BIB0063|stem3004-cit-0063", "doi-asserted-by": "crossref", "first-page": "122", "DOI": "10.4103/ctm.ctm_13_17", "article-title": "A T-cell engager-armed oncolytic vaccinia virus to target the tumor stroma", "volume": "3", "author": "Yu", "year": "2017", "journal-title": "Cancer Transl Med"}, {"key": "10.1002/stem.3004-BIB0064|stem3004-cit-0064", "doi-asserted-by": "crossref", "first-page": "S436", "DOI": "10.1245/s10434-014-3575-z", "article-title": "Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy", "volume": "21", "author": "Yamada", "year": "2014", "journal-title": "Ann Surg Oncol"}, {"key": "10.1002/stem.3004-BIB0065|stem3004-cit-0065", "doi-asserted-by": "crossref", "first-page": "1140", "DOI": "10.4143/crt.2016.491", "article-title": "Engineering of anti-CD133 trispecific molecule capable of inducing NK expansion and driving antibody-dependent cell-mediated cytotoxicity", "volume": "49", "author": "Schmohl", "year": "2017", "journal-title": "Cancer Res Treat"}, {"key": "10.1002/stem.3004-BIB0066|stem3004-cit-0066", "doi-asserted-by": "crossref", "first-page": "170", "DOI": "10.1038/ncb3090", "article-title": "Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth", "volume": "17", "author": "Zhou", "year": "2015", "journal-title": "Nat Cell Biol"}, {"key": "10.1002/stem.3004-BIB0067|stem3004-cit-0067", "doi-asserted-by": "crossref", "first-page": "5350", "DOI": "10.18632/oncotarget.2110", "article-title": "Macrophages are recruited to hypoxic tumor areas and acquire a pro-angiogenic M2-polarized phenotype via hypoxic cancer cell derived cytokines Oncostatin M and Eotaxin", "volume": "5", "author": "Tripathi", "year": "2014", "journal-title": "Oncotarget"}, {"key": "10.1002/stem.3004-BIB0068|stem3004-cit-0068", "doi-asserted-by": "crossref", "first-page": "841", "DOI": "10.1016/j.cell.2018.01.009", "article-title": "CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness", "volume": "172", "author": "Su", "year": "2018", "journal-title": "Cell"}, {"key": "10.1002/stem.3004-BIB0069|stem3004-cit-0069", "doi-asserted-by": "crossref", "first-page": "2134", "DOI": "10.1158/0008-5472.CAN-15-3490", "article-title": "Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors", "volume": "77", "author": "Valenti", "year": "2017", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0070|stem3004-cit-0070", "doi-asserted-by": "crossref", "first-page": "e0125625", "DOI": "10.1371/journal.pone.0125625", "article-title": "Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer", "volume": "10", "author": "Hu", "year": "2015", "journal-title": "PLoS One"}, {"key": "10.1002/stem.3004-BIB0071|stem3004-cit-0071", "doi-asserted-by": "crossref", "first-page": "2897", "DOI": "10.1038/s41467-018-05220-6", "article-title": "Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer", "volume": "9", "author": "Cazet", "year": "2018", "journal-title": "Nat Commun"}, {"key": "10.1002/stem.3004-BIB0072|stem3004-cit-0072", "doi-asserted-by": "crossref", "first-page": "19", "DOI": "10.1186/s40425-019-0505-4", "article-title": "Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager", "volume": "7", "author": "Sostoa", "year": "2019", "journal-title": "J Immunother Cancer"}, {"key": "10.1002/stem.3004-BIB0073|stem3004-cit-0073", "doi-asserted-by": "crossref", "first-page": "6852", "DOI": "10.1158/0008-5472.CAN-18-1750", "article-title": "An oncolytic virus expressing a T-cell engager simultaneously targets cancer and immunosuppressive stromal cells", "volume": "78", "author": "Freedman", "year": "2018", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0074|stem3004-cit-0074", "doi-asserted-by": "crossref", "first-page": "5195", "DOI": "10.1158/0008-5472.CAN-14-0697", "article-title": "Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors", "volume": "74", "author": "Nishio", "year": "2014", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0075|stem3004-cit-0075", "doi-asserted-by": "crossref", "first-page": "2040", "DOI": "10.1158/0008-5472.CAN-16-1577", "article-title": "Armed oncolytic adenovirus-expressing PD-L1 mini-body enhances antitumor effects of chimeric antigen receptor T cells in solid tumors", "volume": "77", "author": "Tanoue", "year": "2017", "journal-title": "Cancer Res"}, {"key": "10.1002/stem.3004-BIB0076|stem3004-cit-0076", "doi-asserted-by": "crossref", "first-page": "2440", "DOI": "10.1016/j.ymthe.2017.09.010", "article-title": "Adenovirotherapy delivering cytokine and checkpoint inhibitor augments CAR T cells against metastatic head and neck cancer", "volume": "25", "author": "Rosewell Shaw", "year": "2017", "journal-title": "Mol Ther"}, {"key": "10.1002/stem.3004-BIB0077|stem3004-cit-0077", "doi-asserted-by": "crossref", "first-page": "e99573", "DOI": "10.1172/jci.insight.99573", "article-title": "Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses", "volume": "3", "author": "Watanabe", "year": "2018", "journal-title": "JCI Insight"}, {"key": "10.1002/stem.3004-BIB0078|stem3004-cit-0078", "doi-asserted-by": "crossref", "first-page": "1219", "DOI": "10.1158/2159-8290.CD-18-0442", "article-title": "Tumor antigen escape from CAR T-cell therapy", "volume": "8", "author": "Majzner", "year": "2018", "journal-title": "Cancer Discov"}, {"key": "10.1002/stem.3004-BIB0079|stem3004-cit-0079", "doi-asserted-by": "crossref", "first-page": "605", "DOI": "10.1158/2326-6066.CIR-17-0314", "article-title": "Improving CART-cell therapy of solid tumors with oncolytic virus-driven production of a bispecific T-cell engager", "volume": "6", "author": "Wing", "year": "2018", "journal-title": "Cancer Immunol Res"}], "container-title": ["STEM CELLS"], "language": "en", "link": [{"URL": "https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fstem.3004", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://onlinelibrary.wiley.com/wol1/doi/10.1002/stem.3004/fullpdf", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 5, 30]], "date-time": "2019-05-30T06:51:02Z", "timestamp": 1559199062000}, "score": 23.749014, "subtitle": ["Targeting Cancer Stem Cells with Oncolytic Viruses"], "issued": {"date-parts": [[2019, 4, 9]]}, "references-count": 79, "journal-issue": {"published-print": {"date-parts": [[2019, 6]]}, "issue": "6"}, "URL": "http://dx.doi.org/10.1002/stem.3004", "archive": ["Portico"], "relation": {"cites": []}, "ISSN": ["1066-5099"], "issn-type": [{"value": "1066-5099", "type": "print"}], "subject": ["Developmental Biology", "Molecular Medicine", "Cell Biology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T11:14:26Z", "timestamp": 1574248466485}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2006, 12, 1]]}, "DOI": "10.1158/1078-0432.ccr-06-1800", "type": "journal-article", "created": {"date-parts": [[2006, 12, 4]], "date-time": "2006-12-04T17:33:26Z", "timestamp": 1165253606000}, "page": "6865-6868", "source": "Crossref", "is-referenced-by-count": 85, "title": ["Pathways Targeting Tumor Lymphangiogenesis"], "prefix": "10.1158", "volume": "12", "author": [{"given": "C.", "family": "Wissmann", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Detmar", "sequence": "additional", "affiliation": []}], "member": "1086", "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-06-1800", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T03:36:34Z", "timestamp": 1482464194000}, "score": 23.688158, "issued": {"date-parts": [[2006, 12, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2006, 12, 1]]}, "issue": "23"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-06-1800", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T23:34:53Z", "timestamp": 1574811293061}, "reference-count": 0, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "344", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Sci. Transl. Med."], "published-print": {"date-parts": [[2016, 6, 22]]}, "DOI": "10.1126/scitranslmed.aag2112", "type": "journal-article", "created": {"date-parts": [[2016, 6, 23]], "date-time": "2016-06-23T23:28:43Z", "timestamp": 1466724523000}, "page": "344ec101-344ec101", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Targeting the cancer cells that just won\u2019t go away"], "prefix": "10.1126", "volume": "8", "author": [{"given": "Kris C.", "family": "Wood", "sequence": "first", "affiliation": []}], "member": "221", "published-online": {"date-parts": [[2016, 6, 22]]}, "container-title": ["Science Translational Medicine"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/scitranslmed.aag2112", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 1, 4]], "date-time": "2018-01-04T23:26:36Z", "timestamp": 1515108396000}, "score": 23.592897, "issued": {"date-parts": [[2016, 6, 22]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 6, 22]]}, "published-print": {"date-parts": [[2016, 6, 22]]}, "issue": "344"}, "alternative-id": ["10.1126/scitranslmed.aag2112"], "URL": "http://dx.doi.org/10.1126/scitranslmed.aag2112", "ISSN": ["1946-6234", "1946-6242"], "issn-type": [{"value": "1946-6234", "type": "print"}, {"value": "1946-6242", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T04:02:57Z", "timestamp": 1575172977882}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "19", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CMC"], "published-print": {"date-parts": [[2005, 9, 1]]}, "DOI": "10.2174/0929867054864886", "type": "journal-article", "created": {"date-parts": [[2005, 8, 30]], "date-time": "2005-08-30T22:52:29Z", "timestamp": 1125442349000}, "page": "2215-2225", "source": "Crossref", "is-referenced-by-count": 38, "title": ["Novel Treatments for Obesity and Osteoporosis: Targeting Apoptotic Pathways in Adipocytes"], "prefix": "10.2174", "volume": "12", "author": [{"given": "C.", "family": "Nelson-Dooley", "sequence": "first", "affiliation": []}, {"given": "M.", "family": "Della-Fera", "sequence": "additional", "affiliation": []}, {"given": "M.", "family": "Hamrick", "sequence": "additional", "affiliation": []}, {"given": "C.", "family": "Baile", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Medicinal Chemistry"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/61721", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 20]], "date-time": "2015-11-20T14:24:37Z", "timestamp": 1448029477000}, "score": 23.396935, "issued": {"date-parts": [[2005, 9, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 9, 1]]}, "issue": "19"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/0929867054864886", "ISSN": ["0929-8673"], "issn-type": [{"value": "0929-8673", "type": "print"}], "subject": ["Molecular Medicine", "Pharmacology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T01:58:38Z", "timestamp": 1574215118000}, "publisher-location": "New York", "reference-count": 99, "publisher": "Springer-Verlag", "isbn-type": [{"value": "0387233849", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1007/0-387-23695-3_9", "type": "book-chapter", "created": {"date-parts": [[2006, 6, 19]], "date-time": "2006-06-19T09:49:02Z", "timestamp": 1150710542000}, "page": "197-212", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Targets for Apoptotic Intervention in Rheumatoid Arthritis"], "prefix": "10.1007", "author": [{"given": "Steven C.", "family": "Ghivizzani", "sequence": "first", "affiliation": []}, {"given": "Elvire", "family": "Gouze", "sequence": "additional", "affiliation": []}, {"given": "Jean-Noel", "family": "Gouze", "sequence": "additional", "affiliation": []}], "member": "297", "reference": [{"key": "9_CR1", "doi-asserted-by": "publisher", "first-page": "655", "DOI": "10.1016/S0092-8674(00)81042-9", "volume": "84", "author": "A.K. Abbas", "year": "1996", "unstructured": "Abbas AK. (1996) Die and let live: eliminating dangerous lymphocytes. Cell, 84:655\u20137.", "journal-title": "Cell"}, {"key": "9_CR2", "doi-asserted-by": "publisher", "first-page": "745", "DOI": "10.1038/nri1184", "volume": "3", "author": "B.B. Aggarwal", "year": "2003", "unstructured": "Aggarwal BB. (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol, 3:745\u201356.", "journal-title": "Nat Rev Immunol"}, {"key": "9_CR3", "doi-asserted-by": "crossref", "first-page": "519", "DOI": "10.1172/JCI8027", "volume": "107", "author": "M. Ali", "year": "2001", "unstructured": "Ali M, Ponchel F, Wilson KE, et al, (2001) Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy. J Clin Invest, 107:519\u201328.", "journal-title": "J Clin Invest"}, {"key": "9_CR4", "doi-asserted-by": "publisher", "first-page": "135", "DOI": "10.1016/0198-8859(92)90039-P", "volume": "34", "author": "G. Angelini", "year": "1992", "unstructured": "Angelini G, Morozzi G, Delfino L, et al, (1992) Analysis of HLA DP, DQ, and DR alleles in adult Italian rheumatoid arthritis patients. Hum Immunol, 34:135\u201341.", "journal-title": "Hum Immunol"}, {"key": "9_CR5", "doi-asserted-by": "publisher", "first-page": "1", "DOI": "10.1053/sarh.2001.23693", "volume": "30", "author": "W.P. Arend", "year": "2001", "unstructured": "Arend WP. (2001) Cytokine imbalance in the pathogenesis of rheumatoid arthritis: the role of interleukin-1 receptor antagonist. Semin Arthritis Rheum, 30:1\u20136.", "journal-title": "Semin Arthritis Rheum"}, {"key": "9_CR6", "first-page": "1091", "volume": "152", "author": "K.R. Aupperle", "year": "1998", "unstructured": "Aupperle KR, Boyle DL, Hendrix M, et al, (1998) Regulation of synoviocyte proliferation, apoptosis, and invasion by the p 53 tumor suppressor gene. Am J Pathol, 152:1091\u20138.", "journal-title": "Am J Pathol"}, {"key": "9_CR7", "doi-asserted-by": "publisher", "first-page": "199", "DOI": "10.1016/S1359-6101(02)00006-0", "volume": "13", "author": "T.M. Baetu", "year": "2002", "unstructured": "Baetu TM & Hiscott J. (2002) On the TRAIL to apoptosis. Cytokine Growth Factor Rev, 13:199\u2013207.", "journal-title": "Cytokine Growth Factor Rev"}, {"key": "9_CR8", "doi-asserted-by": "crossref", "first-page": "141", "DOI": "10.1146/annurev.iy.12.040194.001041", "volume": "12", "author": "P.A. Baeuerle", "year": "1994", "unstructured": "Baeuerle PA & Henkel T. (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol, 12:141\u201379.", "journal-title": "Annu Rev Immunol"}, {"key": "9_CR9", "doi-asserted-by": "publisher", "first-page": "274", "DOI": "10.1097/00002281-200305000-00015", "volume": "15", "author": "A. Baier", "year": "2003", "unstructured": "Baier A, Meineckel I, Gay S & Pap T. (2003) Apoptosis in rheumatoid arthritis. Curr Opin Rheumat, 15:274\u20139.", "journal-title": "Curr Opin Rheumat"}, {"key": "9_CR10", "doi-asserted-by": "publisher", "first-page": "803", "DOI": "10.1016/S0092-8674(00)81265-9", "volume": "85", "author": "M.P. Boldin", "year": "1996", "unstructured": "Boldin MP, Goncharov TM, Goltsev YV & Wallach D. (1996) Involvement of MACH, a novel MORTl/FADD-interacting protease, in Fas/APO-1 and TNF receptor-induced cell death. Cell, 85:803\u201315.", "journal-title": "Cell"}, {"key": "9_CR11", "doi-asserted-by": "publisher", "first-page": "821", "DOI": "10.1016/S1074-7613(00)80400-8", "volume": "7", "author": "P.M. Chaudhary", "year": "1997", "unstructured": "Chaudhary PM, Eby M, Jasmin A, et al, (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. Immunity, 7:821\u201330.", "journal-title": "Immunity"}, {"key": "9_CR12", "doi-asserted-by": "publisher", "first-page": "1634", "DOI": "10.1126/science.1071924", "volume": "296", "author": "G. Chen", "year": "2002", "unstructured": "Chen G & Goeddel DV. (2002) TNF-R1 signaling: a beautiful pathway. Science, 296:1634\u20135.", "journal-title": "Science"}, {"key": "9_CR13", "doi-asserted-by": "publisher", "first-page": "505", "DOI": "10.1016/0092-8674(95)90071-3", "volume": "81", "author": "A.M. Chinnaiyan", "year": "1995", "unstructured": "Chinnaiyan AM, O\u2019Rourke K, Tewari M & Dixit VM. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81:505\u201312.", "journal-title": "Cell"}, {"key": "9_CR14", "doi-asserted-by": "crossref", "first-page": "1399", "DOI": "10.1016/S0002-9440(10)64272-1", "volume": "162", "author": "L.S. Davis", "year": "2003", "unstructured": "Davis LS. (2003) A question of transformation: the synovial fibroblast in rheumatoid arthritis. Am J Pathol, 162:1399\u2013402.", "journal-title": "Am J Pathol"}, {"key": "9_CR15", "doi-asserted-by": "publisher", "first-page": "233", "DOI": "10.1016/S1097-2765(00)80133-1", "volume": "2", "author": "J.M. Desterro", "year": "1998", "unstructured": "Desterro JM, Rodriguez MS & Hay RT. (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol Cell, 2:233\u20139.", "journal-title": "Mol Cell"}, {"key": "9_CR16", "doi-asserted-by": "publisher", "first-page": "1113", "DOI": "10.1007/BF00173494", "volume": "20", "author": "E. Deutsch", "year": "1993", "unstructured": "Deutsch E, Brodack JW & Deutsch KF. (1993) Radiation synovectomy revisited. Eur J Nucl Med, 20:1113\u201327.", "journal-title": "Eur J Nucl Med"}, {"key": "9_CR17", "doi-asserted-by": "publisher", "first-page": "14363", "DOI": "10.1074/jbc.273.23.14363", "volume": "273", "author": "J.G. Emery", "year": "1998", "unstructured": "Emery JG, McDonnell P, Burke MB, et al., (1998) Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. J Biol Chem, 273:14363\u20137.", "journal-title": "J Biol Chem"}, {"key": "9_CR18", "doi-asserted-by": "publisher", "first-page": "723", "DOI": "10.1038/380723a0", "volume": "380", "author": "M. Enari", "year": "1996", "unstructured": "Enari M, Talanian RV, Wong WW & Nagata S. (1996) Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature, 380:723\u20136.", "journal-title": "Nature"}, {"key": "9_CR19", "first-page": "2143", "volume": "149", "author": "G.S. Firestein", "year": "1996", "unstructured": "Firestein GS, Nguyen K, Aupperle KR, et al., (1996) Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol, 149:2143\u201351.", "journal-title": "Am J Pathol"}, {"key": "9_CR20", "doi-asserted-by": "crossref", "first-page": "1631", "DOI": "10.1172/JCI118202", "volume": "96", "author": "G.S. Firestein", "year": "1995", "unstructured": "Firestein GS, Yeo M & Zvaifler NJ (1995) Apoptosis in rheumatoid arthritis synovium. J Clin Invest\n                     96:1631\u20138.", "journal-title": "J Clin Invest"}, {"key": "9_CR21", "doi-asserted-by": "publisher", "first-page": "2024", "DOI": "10.1002/1529-0131(200109)44:9<2024::AID-ART351>3.0.CO;2-K", "volume": "44", "author": "A. Fraser", "year": "2001", "unstructured": "Fraser A, Fearon U, Reece R, et al, (2001) Matrix metalloproteinase 9, apoptosis, and vascular morphology in early arthritis. Arthritis Rheum, 44:2024\u20138.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR22", "doi-asserted-by": "publisher", "first-page": "2320", "DOI": "10.1002/art.10485", "volume": "46", "author": "J.F. Fries", "year": "2002", "unstructured": "Fries JF, Wolfe F, Apple R, et al., (2002) HLA-DRB1 genotype associations in 793 white patients from a rheumatoid arthritis inception cohort: frequency, severity, and treatment bias. Arthritis Rheum, 46:2320\u20139.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR23", "doi-asserted-by": "crossref", "first-page": "271", "DOI": "10.1172/JCI118789", "volume": "98", "author": "K. Fujisawa", "year": "1996", "unstructured": "Fujisawa K, Asahara H, Okamoto K, et al., (1996) Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest, 98:271\u20138.", "journal-title": "J Clin Invest"}, {"key": "9_CR24", "first-page": "3604", "volume": "159", "author": "S.C. Ghivizzani", "year": "1997", "unstructured": "Ghivizzani SC, Kang R, Georgescu HI, et al., (1997) Constitutive intra-articular expression of human IL-1 beta following gene transfer to rabbit synovium produces all major pathologies of human rheumatoid arthritis. J Immunol, 159:3604\u201312.", "journal-title": "J Immunol"}, {"key": "9_CR25", "doi-asserted-by": "publisher", "first-page": "6462", "DOI": "10.1093/emboj/18.22.6462", "volume": "18", "author": "M. Gostissa", "year": "1999", "unstructured": "Gostissa M, Hengstermann A, Fogal V, et al., (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBOJ, 18:6462\u201371.", "journal-title": "EMBOJ"}, {"key": "9_CR26", "doi-asserted-by": "publisher", "first-page": "695", "DOI": "10.1016/S0092-8674(00)81728-6", "volume": "94", "author": "D.R. Green", "year": "1998", "unstructured": "Green DR. (1998) Apoptotic pathways: the roads to ruin. Cell, 94, 695\u20138.", "journal-title": "Cell"}, {"key": "9_CR27", "doi-asserted-by": "publisher", "first-page": "1156", "DOI": "10.1074/jbc.274.2.1156", "volume": "274", "author": "A. Gross", "year": "1999", "unstructured": "Gross A, Yin XM, Wang K, et al., (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem, 274:1156\u201363.", "journal-title": "J Biol Chem"}, {"key": "9_CR28", "doi-asserted-by": "crossref", "first-page": "1762", "DOI": "10.1002/art.1780381209", "volume": "38", "author": "M.L. Handel", "year": "1995", "unstructured": "Handel ML, McMorrow LB & Gravallese EM. (1995) Nuclear factor-kappa B in rheumatoid synovium. Localization of p50 and p65. Arthritis Rheum, 38:1762\u201370.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR29", "first-page": "93", "volume": "63", "author": "P. Hilliquin", "year": "1996", "unstructured": "Hilliquin P, Le Devic P & Menkes CJ. (1996) Comparison of the efficacy of nonsurgical synovectomy (synoviorthesis) and joint lavage in knee osteoarthritis with effusions. Rev Rhum Engl Ed, 63:93\u2013102.", "journal-title": "Rev Rhum Engl Ed"}, {"key": "9_CR30", "doi-asserted-by": "crossref", "first-page": "6217", "DOI": "10.4049/jimmunol.167.11.6217", "volume": "167", "author": "A.M. Hohlbaum", "year": "2001", "unstructured": "Hohlbaum AM, Gregory MS, Ju ST & Marshak-Rothstein A. (2001) Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J Immunol, 167:6217\u201324.", "journal-title": "J Immunol"}, {"key": "9_CR31", "doi-asserted-by": "crossref", "first-page": "1061", "DOI": "10.4049/jimmunol.171.2.1061", "volume": "171", "author": "K. Ichikawa", "year": "2003", "unstructured": "Ichikawa K, Liu W, Fleck M, et al., (2003) TRAIL-R2 (DR5) mediates apoptosis of synovial fibroblasts in rheumatoid arthritis. J Immunol, 171:1061\u20139.", "journal-title": "J Immunol"}, {"key": "9_CR32", "doi-asserted-by": "publisher", "first-page": "221", "DOI": "10.1038/ni0302-221", "volume": "3", "author": "M. Karin", "year": "2002", "unstructured": "Karin M & Lin A. (2002) NF-kappaB at the crossroads of life and death. Nat Immunol, 3:221\u20137.", "journal-title": "Nat Immunol"}, {"key": "9_CR33", "doi-asserted-by": "crossref", "first-page": "1267", "DOI": "10.1002/art.1780390802", "volume": "39", "author": "A. Kawakami", "year": "1996", "unstructured": "Kawakami A, Eguchi K, Matsuoka N, et al., (1996) Inhibition of Fas antigen-mediated apoptosis of rheumatoid synovial cells in vitro by transforming growth factor beta 1. Arthritis Rheum, 39:1267\u201376.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR34", "doi-asserted-by": "crossref", "first-page": "4025", "DOI": "10.1002/j.1460-2075.1991.tb04978.x", "volume": "10", "author": "J. Keffer", "year": "1991", "unstructured": "Keffer J, Probert L, Cazlaris H, et al., (1991) Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J, 10:4025\u201331.", "journal-title": "EMBO J"}, {"key": "9_CR35", "doi-asserted-by": "publisher", "first-page": "297", "DOI": "10.1016/S1074-7613(00)80535-X", "volume": "8", "author": "M.A. Kelliher", "year": "1998", "unstructured": "Kelliher MA, Grimm S, Ishida Y, et al., (1998) The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. Immunity, 8:297\u2013303.", "journal-title": "Immunity"}, {"key": "9_CR36", "doi-asserted-by": "publisher", "first-page": "584", "DOI": "10.1016/S1525-0016(02)90712-4", "volume": "6", "author": "S.H. Kim", "year": "2002", "unstructured": "Kim SH, Kim S, Oligino TJ & Robbins PD. (2002) Effective treatment of established mouse collagen-induced arthritis by systemic administration of dendritic cells genetically modified to express FasL. Mol Ther, 6:584\u201390.", "journal-title": "Mol Ther"}, {"key": "9_CR37", "doi-asserted-by": "crossref", "first-page": "5579", "DOI": "10.1002/j.1460-2075.1995.tb00245.x", "volume": "14", "author": "F.C. Kischkel", "year": "1995", "unstructured": "Kischkel FC, Hellbardt S, Behrmann I, et al., (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J, 14:5579\u201388.", "journal-title": "EMBO J"}, {"key": "9_CR38", "doi-asserted-by": "publisher", "first-page": "255", "DOI": "10.1038/ni894", "volume": "4", "author": "S.E. Lamhamedi-Cherradi", "year": "2003", "unstructured": "Lamhamedi-Cherradi SE, Zheng SJ, Maguschak KA, et al., (2003) Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL-/-mice. Nat Immunol, 4:255\u201360.", "journal-title": "Nat Immunol"}, {"key": "9_CR39", "doi-asserted-by": "publisher", "first-page": "1291", "DOI": "10.1038/nm1201-1291", "volume": "7", "author": "T. Lawrence", "year": "2001", "unstructured": "Lawrence T, Gilroy DW, Colville-Nash PR & Willoughby DA. (2001) Possible new role for NF-kappaB in the resolution of inflammation. Nat Med, 7:1291\u20137.", "journal-title": "Nat Med"}, {"key": "9_CR40", "doi-asserted-by": "publisher", "first-page": "66", "DOI": "10.1038/sj.cdd.4401187", "volume": "10", "author": "H.N. LeBlanc", "year": "2003", "unstructured": "LeBlanc HN & Ashkenazi A. (2003) Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ, 10:66\u201375.", "journal-title": "Cell Death Differ"}, {"key": "9_CR41", "doi-asserted-by": "publisher", "first-page": "655", "DOI": "10.1016/S1074-7613(03)00092-X", "volume": "18", "author": "D.F. Legler", "year": "2003", "unstructured": "Legler DF, Micheau O, Doucey MA, et al., (2003) Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity, 18:655\u201364.", "journal-title": "Immunity"}, {"key": "9_CR42", "doi-asserted-by": "publisher", "first-page": "479", "DOI": "10.1016/S0092-8674(00)80434-1", "volume": "91", "author": "P. Li", "year": "1997", "unstructured": "Li P, Nijhawan D, Budihardjo I, et al., (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91:479\u201389.", "journal-title": "Cell"}, {"key": "9_CR43", "doi-asserted-by": "crossref", "first-page": "1907", "DOI": "10.4049/jimmunol.172.3.1907", "volume": "172", "author": "H. Liu", "year": "2004", "unstructured": "Liu H, Ma Y, Pagliari LJ, et al., (2004) TNF-alpha-induced apoptosis of macrophages following inhibition of NF-kappa B: a central role for disruption of mitochondria. J Immunol, 172:1907\u201315.", "journal-title": "J Immunol"}, {"key": "9_CR44", "doi-asserted-by": "publisher", "first-page": "317", "DOI": "10.1016/S1471-4892(03)00037-7", "volume": "3", "author": "H. Liu", "year": "2003", "unstructured": "Liu H & Pope RM. (2003) The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol, 3:317\u201322.", "journal-title": "Curr Opin Pharmacol"}, {"key": "9_CR45", "doi-asserted-by": "publisher", "first-page": "1332", "DOI": "10.1172/JCI200319209", "volume": "112", "author": "Z. Liu", "year": "2003", "unstructured": "Liu Z, Xu X, Hsu HC, et al., (2003) CII-DC-AdTRAIL cell gene therapy inhibits infiltration of CII-reactive cells and CII-induced arthritis. J Clin Invest, 112:1332\u201341.", "journal-title": "J Clin Invest"}, {"key": "9_CR46", "doi-asserted-by": "publisher", "first-page": "481", "DOI": "10.1016/S0092-8674(00)81589-5", "volume": "94", "author": "X. Luo", "year": "1998", "unstructured": "Luo X, Budihardjo I, Zou H, et al., (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell, 94:481\u201390.", "journal-title": "Cell"}, {"key": "9_CR47", "doi-asserted-by": "publisher", "first-page": "1003", "DOI": "10.1016/S0960-9822(06)00422-2", "volume": "7", "author": "S.A. Marsters", "year": "1997", "unstructured": "Marsters SA, Sheridan JP, Pitti RM, et al., (1997) A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr Biol, 7:1003\u20136.", "journal-title": "Curr Biol"}, {"key": "9_CR48", "first-page": "1345", "volume": "23", "author": "S. Matsumoto", "year": "1996", "unstructured": "Matsumoto S, Muller-Ladner U, Gay RE, et al., (1996) Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol, 23:1345\u201352.", "journal-title": "J Rheumatol"}, {"key": "9_CR49", "doi-asserted-by": "publisher", "first-page": "65", "DOI": "10.1093/rheumatology/18.2.65", "volume": "18", "author": "C.J. Menkes", "year": "1979", "unstructured": "Menkes CJ. (1979) Is there a place for chemical and radiation synovectomy in rheumatic diseases? Rheumatol Rehabil, 18:65\u201377.", "journal-title": "Rheumatol Rehabil"}, {"key": "9_CR50", "doi-asserted-by": "publisher", "first-page": "295", "DOI": "10.1016/S1525-0016(03)00181-3", "volume": "8", "author": "Z. Mi", "year": "2003", "unstructured": "Mi Z, Lu X, Mai JC, et al., (2003) Identification of a synovial fibroblast-specific protein transduction domain for delivery of apoptotic agents to hyperplastic synovium. Mol Ther, 8:295\u2013305.", "journal-title": "Mol Ther"}, {"key": "9_CR51", "doi-asserted-by": "publisher", "first-page": "13859", "DOI": "10.1073/pnas.95.23.13859", "volume": "95", "author": "A.V. Miagkov", "year": "1998", "unstructured": "Miagkov AV, Kovalenko DV, Brown CE, et al., (1998) NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA, 95:13859\u201364.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR52", "doi-asserted-by": "publisher", "first-page": "13321", "DOI": "10.1074/jbc.275.18.13321", "volume": "275", "author": "S. Muller", "year": "2000", "unstructured": "Muller S, Berger M, Lehembre F, et al., (2000) c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem, 275:13321\u20139.", "journal-title": "J Biol Chem"}, {"key": "9_CR53", "first-page": "1607", "volume": "149", "author": "U. Muller-Ladner", "year": "1996", "unstructured": "Muller-Ladner U, Kriegsmann J, Franklin BN, et al., (1996) Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol, 149:1607\u201315.", "journal-title": "Am J Pathol"}, {"key": "9_CR54", "doi-asserted-by": "publisher", "first-page": "817", "DOI": "10.1016/S0092-8674(00)81266-0", "volume": "85", "author": "M. Muzio", "year": "1996", "unstructured": "Muzio M, Chinnaiyan AM, Kischkel FC, et al., (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death\u2014inducing signaling complex. Cell, 85:817\u201327.", "journal-title": "Cell"}, {"key": "9_CR55", "doi-asserted-by": "publisher", "first-page": "2926", "DOI": "10.1074/jbc.273.5.2926", "volume": "273", "author": "M. Muzio", "year": "1998", "unstructured": "Muzio M, Stockwell BR, Stennicke HR, et al., (1998) An induced proximity model for caspase-8 activation. J Biol Chem, 273:2926\u201330.", "journal-title": "J Biol Chem"}, {"key": "9_CR56", "doi-asserted-by": "publisher", "first-page": "355", "DOI": "10.1016/S0092-8674(00)81874-7", "volume": "88", "author": "S. Nagata", "year": "1997", "unstructured": "Nagata S. (1997) Apoptosis by death factor. Cell, 88:355\u201365.", "journal-title": "Cell"}, {"key": "9_CR57", "doi-asserted-by": "crossref", "first-page": "1449", "DOI": "10.1126/science.7533326", "volume": "267", "author": "S. Nagata", "year": "1995", "unstructured": "Nagata S & Golstein P. (1995) The Fas death factor. Science, 267:1449\u201356.", "journal-title": "Science"}, {"key": "9_CR58", "doi-asserted-by": "crossref", "first-page": "485", "DOI": "10.1002/art.1780380405", "volume": "38", "author": "T. Nakajima", "year": "1995", "unstructured": "Nakajima T, Aono H, Hasunuma T, et al., (1995) Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum, 38:485\u201391.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR59", "doi-asserted-by": "crossref", "first-page": "6590", "DOI": "10.4049/jimmunol.165.11.6590", "volume": "165", "author": "T. Nanki", "year": "2000", "unstructured": "Nanki T, Hayashida K, El-Gabalawy HS, et al., (2000) Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol, 165:6590\u20138.", "journal-title": "J Immunol"}, {"key": "9_CR60", "doi-asserted-by": "publisher", "first-page": "331", "DOI": "10.1038/sj.gt.3300597", "volume": "5", "author": "K. Okamoto", "year": "1998", "unstructured": "Okamoto K, Asahara H, Kobayashi T, et al., (1998) Induction of apoptosis in the rheumatoid synovium by Fas ligand gene transfer. Gene Ther, 5:331\u20138.", "journal-title": "Gene Ther"}, {"key": "9_CR61", "first-page": "4277", "volume": "157", "author": "T. Okura", "year": "1996", "unstructured": "Okura T, Gong L, Kamitani T, et al, (1996) Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol, 157:4277\u201381.", "journal-title": "J Immunol"}, {"key": "9_CR62", "doi-asserted-by": "publisher", "first-page": "815", "DOI": "10.1126/science.277.5327.815", "volume": "277", "author": "G. Pan", "year": "1997", "unstructured": "Pan G, Ni J, Wei YF, et al., (1997a) An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science, 277:815\u201318.", "journal-title": "Science"}, {"key": "9_CR63", "doi-asserted-by": "publisher", "first-page": "111", "DOI": "10.1126/science.276.5309.111", "volume": "276", "author": "G. Pan", "year": "1997", "unstructured": "Pan G, O\u2019Rourke K, Chinnaiyan AM, et al., (1997b) The receptor for the cytotoxic ligand TRAIL. Science, 276:111\u201313.", "journal-title": "Science"}, {"key": "9_CR64", "doi-asserted-by": "publisher", "first-page": "361", "DOI": "10.1186/ar113", "volume": "2", "author": "T. Pap", "year": "2000", "unstructured": "Pap T, Muller-Ladner U, Gay RE & Gay S. (2000) Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res, 2, 361\u20137.", "journal-title": "Arthritis Res"}, {"key": "9_CR65", "doi-asserted-by": "publisher", "first-page": "2899", "DOI": "10.1002/1529-0131(200112)44:12<2899::AID-ART478>3.0.CO;2-X", "volume": "44", "author": "H. Perlman", "year": "2001", "unstructured": "Perlman H, Liu H, Georganas C, et al., (2001) Differential expression pattern of the antiapoptotic proteins, Bcl-2 and FLIP, in experimental arthritis. Arthritis Rheum, 44:2899\u2013908.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR66", "doi-asserted-by": "publisher", "first-page": "1679", "DOI": "10.1084/jem.190.11.1679", "volume": "190", "author": "H. Perlman", "year": "1999", "unstructured": "Perlman H, Pagliari LJ, Georganas, C, et al., (1999) FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med, 190:1679\u201388.", "journal-title": "J Exp Med"}, {"key": "9_CR67", "doi-asserted-by": "publisher", "first-page": "527", "DOI": "10.1038/nri846", "volume": "2", "author": "R.M. Pope", "year": "2002", "unstructured": "Pope RM. (2002) Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol, 2:527\u201335.", "journal-title": "Nat Rev Immunol"}, {"key": "9_CR68", "doi-asserted-by": "publisher", "first-page": "6455", "DOI": "10.1093/emboj/18.22.6455", "volume": "18", "author": "M.S. Rodriguez", "year": "1999", "unstructured": "Rodriguez MS, Desterro JM, Lain S, et al., (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J, 18:6455\u201361.", "journal-title": "EMBO J"}, {"key": "9_CR69", "doi-asserted-by": "publisher", "first-page": "101", "DOI": "10.1016/S0889-857X(05)70380-X", "volume": "24", "author": "A. Rosen", "year": "1998", "unstructured": "Rosen A & Weiland AJ (1998) Rheumatoid arthritis of the wrist and hand. Rheu Dis Clin North Am\n                     24:101\u201328.", "journal-title": "Rheu Dis Clin North Am"}, {"key": "9_CR70", "doi-asserted-by": "publisher", "first-page": "1251", "DOI": "10.1002/1529-0131(199807)41:7<1251::AID-ART16>3.0.CO;2-B", "volume": "41", "author": "K. Sakai", "year": "1998", "unstructured": "Sakai K, Matsuno H, Morita I, et al., (1998) Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis. Arthritis Rheum, 41:1251\u20137.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR71", "doi-asserted-by": "crossref", "first-page": "375", "DOI": "10.1002/jlb.61.4.375", "volume": "61", "author": "J. Savill", "year": "1997", "unstructured": "Savill J. (1997) Apoptosis in resolution of inflammation. J Leukoc Biol, 61:375\u201380.", "journal-title": "J Leukoc Biol"}, {"key": "9_CR72", "doi-asserted-by": "publisher", "first-page": "1512", "DOI": "10.1002/art.10309", "volume": "46", "author": "J. Schedel", "year": "2002", "unstructured": "Schedel J, Gay RE, Kuenzler P, et al., (2002) FLICE-inhibitory protein expression in synovial fibroblasts and at sites of cartilage and bone erosion in rheumatoid arthritis. Arthritis Rheum, 46:1512\u20138.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR73", "first-page": "1018", "volume": "161", "author": "M. Schirmer", "year": "1998", "unstructured": "Schirmer M, Vallejo AN, Weyand CM & Goronzy JJ. (1998) Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4+CD28-T cells from rheumatoid arthritis patients. J Immunol, 161:1018\u201325.", "journal-title": "J Immunol"}, {"key": "9_CR74", "doi-asserted-by": "publisher", "first-page": "143", "DOI": "10.1016/S0889-857X(05)70382-3", "volume": "24", "author": "T.P. Sculco", "year": "1998", "unstructured": "Sculco TP. (1998) The knee joint in rheumatoid arthritis. Rheum Dis Clin North Am, 24:143\u201356.", "journal-title": "Rheum Dis Clin North Am"}, {"key": "9_CR75", "doi-asserted-by": "publisher", "first-page": "818", "DOI": "10.1126/science.277.5327.818", "volume": "277", "author": "J.P. Sheridan", "year": "1997", "unstructured": "Sheridan JP, Marsters SA, Pitti RM, et al., (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science, 277:818\u201321.", "journal-title": "Science"}, {"key": "9_CR76", "doi-asserted-by": "publisher", "first-page": "1095", "DOI": "10.1084/jem.191.7.1095", "volume": "191", "author": "K. Song", "year": "2000", "unstructured": "Song K, Chen Y, Goke R, et al., (2000) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med, 191:1095\u2013104.", "journal-title": "J Exp Med"}, {"key": "9_CR77", "doi-asserted-by": "publisher", "first-page": "211", "DOI": "10.1084/jem.188.1.211", "volume": "188", "author": "C. Stehlik", "year": "1998", "unstructured": "Stehlik C, de Martin R, Kumabashiri I, et al., (1998) Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med, 188:211\u201316.", "journal-title": "J Exp Med"}, {"key": "9_CR78", "first-page": "3734", "volume": "8", "author": "J. Strater", "year": "2002", "unstructured": "Strater J, Hinz U, Walczak H, et al, (2002) Expression of TRAIL and TRAIL receptors in colon carcinoma: TRAIL-R1 is an independent prognostic parameter. Clin Cancer Res, 8:3734\u201340.", "journal-title": "Clin Cancer Res"}, {"key": "9_CR79", "doi-asserted-by": "publisher", "first-page": "442", "DOI": "10.1136/ard.55.7.442", "volume": "55", "author": "M. Sugiyama", "year": "1996", "unstructured": "Sugiyama M, Tsukazaki T, Yonekura A, et al., (1996) Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis, 55:442\u20139.", "journal-title": "Ann Rheum Dis"}, {"key": "9_CR80", "doi-asserted-by": "crossref", "first-page": "3064", "DOI": "10.4049/jimmunol.167.6.3064", "volume": "167", "author": "Y. Suzuki", "year": "2001", "unstructured": "Suzuki Y, Rahman M & Mitsuya H. (2001) Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-l: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol, 167:3064\u201373.", "journal-title": "J Immunol"}, {"key": "9_CR81", "doi-asserted-by": "publisher", "first-page": "36530", "DOI": "10.1074/jbc.M104837200", "volume": "276", "author": "K. Tada", "year": "2001", "unstructured": "Tada K, Okazaki T, Sakon S, et al., (2001) Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J Biol Chem, 276:36530\u20134.", "journal-title": "J Biol Chem"}, {"key": "9_CR82", "doi-asserted-by": "publisher", "first-page": "948", "DOI": "10.1002/1529-0131(199905)42:5<948::AID-ANR13>3.0.CO;2-L", "volume": "42", "author": "P.P. Tak", "year": "1999", "unstructured": "Tak PP, Smeets TJ, Boyle DL, et al, (1999) p53 overexpression in synovial tissue from patients with early and longstanding rheumatoid arthritis compared with patients with reactive arthritis and osteoarthritis. Arthritis Rheum, 42:948\u201353.", "journal-title": "Arthritis Rheum"}, {"key": "9_CR83", "doi-asserted-by": "publisher", "first-page": "77", "DOI": "10.1016/S0167-5699(99)01552-2", "volume": "21", "author": "P.P. Tak", "year": "2000", "unstructured": "Tak PP, Zvaifler NJ, Green DR & Firestein GS. (2000) Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today, 21:77\u201382.", "journal-title": "Immunol Today"}, {"key": "9_CR84", "doi-asserted-by": "publisher", "first-page": "1100", "DOI": "10.1093/rheumatology/36.10.1100", "volume": "36", "author": "W.J. Taylor", "year": "1997", "unstructured": "Taylor WJ, Corkill MM & Rajapaske CN. (1997) A retrospective review of yttrium-90 synovectomy in the treatment of knee arthritis. Br J Rheumatol, 36:1100\u201305.", "journal-title": "Br J Rheumatol"}, {"key": "9_CR85", "doi-asserted-by": "publisher", "first-page": "1312", "DOI": "10.1126/science.281.5381.1312", "volume": "281", "author": "N.A. Thornberry", "year": "1998", "unstructured": "Thornberry NA & Lazebnik Y. (1998) Caspases: enemies within. Science, 281:1312\u201316.", "journal-title": "Science"}, {"key": "9_CR86", "first-page": "7981", "volume": "73", "author": "T. Tsukahara", "year": "1999", "unstructured": "Tsukahara T, Kannagi M, Ohashi T, et al (1999) Induction of Bcl-x(L) expression by human T-cell leukemia virus type 1 Tax through NF-\u03baB in apoptosis-resistant T-cell transfectants with Tax. J Virol, 73:7981\u20137.", "journal-title": "J Virol"}, {"key": "9_CR87", "doi-asserted-by": "publisher", "first-page": "388", "DOI": "10.1016/S0968-0004(97)01107-9", "volume": "22", "author": "P. Villa", "year": "1997", "unstructured": "Villa P Kaufmann SH & Earnshaw WC (1997) Caspases and caspase inhibitors. Trends Biochem Sci\n                     22:388\u201393.", "journal-title": "Trends Biochem Sci"}, {"key": "9_CR88", "doi-asserted-by": "publisher", "first-page": "5386", "DOI": "10.1093/emboj/16.17.5386", "volume": "16", "author": "H. Walczak", "year": "1997", "unstructured": "Walczak H, Degli-Esposti MA, Johnson RS, et al., (1997) TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBOJ, 16:5386\u201397.", "journal-title": "EMBOJ"}, {"key": "9_CR89", "doi-asserted-by": "publisher", "first-page": "1680", "DOI": "10.1126/science.281.5383.1680", "volume": "281", "author": "C.Y. Wang", "year": "1998", "unstructured": "Wang CY, Mayo MW, Korneluk RG, et al., (1998) NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 281:1680\u20133.", "journal-title": "Science"}, {"key": "9_CR90", "doi-asserted-by": "crossref", "first-page": "2859", "DOI": "10.1101/gad.10.22.2859", "volume": "10", "author": "K. Wang", "year": "1996", "unstructured": "Wang K, Yin XM, Chao DT et al (1996) BID: a novel BH3 domain-only death agonist. Genes Dev\n                     10:2859\u201369.", "journal-title": "Genes Dev"}, {"key": "9_CR91", "doi-asserted-by": "crossref", "first-page": "2270", "DOI": "10.4049/jimmunol.166.4.2270", "volume": "166", "author": "Y. Yamamura", "year": "2001", "unstructured": "Yamamura Y, Gupta R, Morita Y, et al., (2001) Effector function of resting T cells: activation of synovial fibroblasts. J Immunol, 166:2270\u20135.", "journal-title": "J Immunol"}, {"key": "9_CR92", "doi-asserted-by": "publisher", "first-page": "10025", "DOI": "10.1073/pnas.152333199", "volume": "99", "author": "Y. Yamanishi", "year": "2002", "unstructured": "Yamanishi Y, Boyle DL, Rosengren S, et al., (2002) Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA, 99:10025\u201330.", "journal-title": "Proc Natl Acad Sci USA"}, {"key": "9_CR93", "doi-asserted-by": "publisher", "first-page": "210", "DOI": "10.1002/(SICI)1521-2254(200005/06)2:3<210::AID-JGM101>3.0.CO;2-P", "volume": "2", "author": "Q. Yao", "year": "2000", "unstructured": "Yao Q, Glorioso JC, Evans CH., et al., (2000) Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining. J Gene Med, 2:210\u201319.", "journal-title": "J Gene Med"}, {"key": "9_CR94", "doi-asserted-by": "publisher", "first-page": "1055", "DOI": "10.1038/sj.gt.3301881", "volume": "10", "author": "Q. Yao", "year": "2003", "unstructured": "Yao Q, Wang S, Gambotto A, et al., (2003) Intra-articular adenoviral-mediated gene transfer of trail induces apoptosis of arthritic rabbit synovium. Gene Ther, 10:1055\u201360.", "journal-title": "Gene Ther"}, {"key": "9_CR95", "doi-asserted-by": "publisher", "first-page": "715", "DOI": "10.1016/S1074-7613(00)80391-X", "volume": "7", "author": "W.C. Yeh", "year": "1997", "unstructured": "Yeh WC, Shahinian A, Speiser D, et al., (1997) Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity, 7:715\u201325.", "journal-title": "Immunity"}, {"key": "9_CR96", "doi-asserted-by": "publisher", "first-page": "732", "DOI": "10.1161/01.RES.0000067928.83455.9C", "volume": "92", "author": "G. Zauli", "year": "2003", "unstructured": "Zauli G, Pandolfi A, Gonelli A, et al., (2003) Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. Circ Res, 92:732\u2013740.", "journal-title": "Circ Res"}, {"key": "9_CR97", "doi-asserted-by": "publisher", "first-page": "1951", "DOI": "10.1172/JCI119726", "volume": "100", "author": "H. Zhang", "year": "1997", "unstructured": "Zhang H, Yang Y, Horton JL, et al., (1997) Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Invest, 100:1951\u20137.", "journal-title": "J Clin Invest"}, {"key": "9_CR98", "doi-asserted-by": "crossref", "first-page": "4981", "DOI": "10.4049/jimmunol.166.8.4981", "volume": "166", "author": "J. Zhang", "year": "2001", "unstructured": "Zhang J, Bardos T, Mikecz K, et al., (2001) Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis. J Immunol, 166:4981\u20136.", "journal-title": "J Immunol"}, {"key": "9_CR99", "doi-asserted-by": "publisher", "first-page": "296", "DOI": "10.1038/32681", "volume": "392", "author": "J. Zhang", "year": "1998", "unstructured": "Zhang J, Cado D, Chen A, et al., (1998) Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1. Nature\n                     392:296\u2013300.", "journal-title": "Nature"}], "container-title": ["Apoptotic Pathways as Targets for Novel Therapies in Cancer and Other Diseases"], "link": [{"URL": "http://www.springerlink.com/index/pdf/10.1007/0-387-23695-3_9", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 2, 11]], "date-time": "2019-02-11T08:45:20Z", "timestamp": 1549874720000}, "score": 23.080334, "issued": {"date-parts": [[null]]}, "ISBN": ["0387233849"], "references-count": 99, "URL": "http://dx.doi.org/10.1007/0-387-23695-3_9", "relation": {"cites": []}}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T05:09:15Z", "timestamp": 1575176955853}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "16", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2005, 8, 15]]}, "DOI": "10.1158/1078-0432.ccr-05-0637", "type": "journal-article", "created": {"date-parts": [[2005, 9, 21]], "date-time": "2005-09-21T23:49:41Z", "timestamp": 1127346581000}, "page": "5847-5855", "source": "Crossref", "is-referenced-by-count": 79, "title": ["Proteomic Analysis of Apoptotic Pathways Reveals Prognostic Factors in Follicular Lymphoma"], "prefix": "10.1158", "volume": "11", "author": [{"given": "C.", "family": "Gulmann", "sequence": "first", "affiliation": []}], "member": "1086", "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-05-0637", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T11:56:43Z", "timestamp": 1482494203000}, "score": 22.774563, "issued": {"date-parts": [[2005, 8, 15]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2005, 8, 15]]}, "issue": "16"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-05-0637", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T08:52:40Z", "timestamp": 1575190360023}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "23", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Cancer Res"], "published-print": {"date-parts": [[2005, 12, 1]]}, "DOI": "10.1158/0008-5472.can-05-0118", "type": "journal-article", "created": {"date-parts": [[2005, 12, 1]], "date-time": "2005-12-01T20:48:14Z", "timestamp": 1133470094000}, "page": "10646-10650", "source": "Crossref", "is-referenced-by-count": 50, "title": ["Enhanced Targeting and Killing of Tumor Cells Expressing the CXC Chemokine Receptor 4 by Transducible Anticancer Peptides"], "prefix": "10.1158", "volume": "65", "author": [{"given": "Eric L.", "family": "Snyder", "sequence": "first", "affiliation": []}, {"given": "Cheryl C.", "family": "Saenz", "sequence": "additional", "affiliation": []}, {"given": "Catherine", "family": "Denicourt", "sequence": "additional", "affiliation": []}, {"given": "Bryan R.", "family": "Meade", "sequence": "additional", "affiliation": []}, {"given": "Xian-Shu", "family": "Cui", "sequence": "additional", "affiliation": []}, {"given": "Ian M.", "family": "Kaplan", "sequence": "additional", "affiliation": []}, {"given": "Steven F.", "family": "Dowdy", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2005, 12, 1]]}, "container-title": ["Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/0008-5472.CAN-05-0118", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 7, 21]], "date-time": "2017-07-21T22:42:41Z", "timestamp": 1500676961000}, "score": 22.308388, "issued": {"date-parts": [[2005, 12, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2005, 12, 1]]}, "published-print": {"date-parts": [[2005, 12, 1]]}, "issue": "23"}, "alternative-id": ["10.1158/0008-5472.CAN-05-0118"], "URL": "http://dx.doi.org/10.1158/0008-5472.can-05-0118", "ISSN": ["0008-5472", "1538-7445"], "issn-type": [{"value": "0008-5472", "type": "print"}, {"value": "1538-7445", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T20:10:56Z", "timestamp": 1574280656654}, "reference-count": 0, "publisher": "Bentham Science Publishers Ltd.", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["CPD"], "published-print": {"date-parts": [[2007, 2, 1]]}, "DOI": "10.2174/138161207780162917", "type": "journal-article", "created": {"date-parts": [[2007, 3, 13]], "date-time": "2007-03-13T06:26:36Z", "timestamp": 1173767196000}, "page": "463-470", "source": "Crossref", "is-referenced-by-count": 15, "title": ["Targeting Different Signaling Pathways with Antisense Oligonucleotides Combination for Cancer Therapy"], "prefix": "10.2174", "volume": "13", "author": [{"given": "C.", "family": "Leonetti", "sequence": "first", "affiliation": []}, {"given": "G.", "family": "Zupi", "sequence": "additional", "affiliation": []}], "member": "965", "container-title": ["Current Pharmaceutical Design"], "language": "en", "link": [{"URL": "http://eurekaselect.com/article/download/58884", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2015, 11, 20]], "date-time": "2015-11-20T14:14:38Z", "timestamp": 1448028878000}, "score": 22.144646, "issued": {"date-parts": [[2007, 2, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 2, 1]]}, "issue": "5"}, "alternative-id": ["LiveAll1"], "URL": "http://dx.doi.org/10.2174/138161207780162917", "ISSN": ["1381-6128"], "issn-type": [{"value": "1381-6128", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T16:24:05Z", "timestamp": 1574699045701}, "reference-count": 0, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "6239", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science"], "published-print": {"date-parts": [[2015, 6, 5]]}, "DOI": "10.1126/science.348.6239.1164-c", "type": "journal-article", "created": {"date-parts": [[2015, 6, 4]], "date-time": "2015-06-04T18:56:17Z", "timestamp": 1433444177000}, "page": "1164-1164", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Part 3: Targeting Cancer Pathways: Tumor Metabolism and Proliferation"], "prefix": "10.1126", "volume": "348", "author": [{"given": "M. C.", "family": "Simon", "sequence": "first", "affiliation": []}, {"given": "N.", "family": "Hay", "sequence": "additional", "affiliation": []}], "member": "221", "published-online": {"date-parts": [[2015, 6, 4]]}, "container-title": ["Science"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/science.348.6239.1164-c", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T18:10:14Z", "timestamp": 1482516614000}, "score": 21.893738, "issued": {"date-parts": [[2015, 6, 4]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 6, 4]]}, "published-print": {"date-parts": [[2015, 6, 5]]}, "issue": "6239"}, "URL": "http://dx.doi.org/10.1126/science.348.6239.1164-c", "ISSN": ["0036-8075", "1095-9203"], "issn-type": [{"value": "0036-8075", "type": "print"}, {"value": "1095-9203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T19:28:12Z", "timestamp": 1574278092392}, "reference-count": 0, "publisher": "Ecancer Global Foundation", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["ecancer"], "published-print": {"date-parts": [[2009, 1, 1]]}, "DOI": "10.3332/ecancer.2008.115", "type": "journal-article", "created": {"date-parts": [[2009, 1, 30]], "date-time": "2009-01-30T15:07:38Z", "timestamp": 1233328058000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Molecular characterisation of signalling pathways in cancer stem cells"], "prefix": "10.3332", "volume": "3", "author": [{"given": "C", "family": "Regenbrecht", "sequence": "first", "affiliation": []}], "member": "1871", "container-title": ["ecancermedicalscience"], "link": [{"URL": "http://ecancer.org/journal/2/pdf/115-molecular-characterisation-of-signalling-pathways-in-cancer-stem-cells.php", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 8]], "date-time": "2016-12-08T14:54:03Z", "timestamp": 1481208843000}, "score": 21.712023, "issued": {"date-parts": [[2009, 1, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3332/ecancer.2008.115", "ISSN": ["1754-6605"], "issn-type": [{"value": "1754-6605", "type": "electronic"}]}, {"institution": {"name": "Signaling Pathways Project", "place": ["-"], "acronym": ["SPP"]}, "indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T21:20:25Z", "timestamp": 1575494425328}, "reference-count": 0, "publisher": "Signaling Pathways Project", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1621/9ub54hewlh", "type": "dataset", "created": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T15:32:45Z", "timestamp": 1565364765000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysis of the FOXA1 cistrome in human LNCaP-abl prostate cancer cells"], "prefix": "10.1621", "author": [{"given": "C", "family": "Zang", "sequence": "first", "affiliation": []}], "member": "625", "container-title": ["Signaling Pathways Project Datasets"], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T15:39:29Z", "timestamp": 1565365169000}, "score": 21.712023, "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1621/9ub54hewlh"}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T03:18:52Z", "timestamp": 1575256732834}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "21", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clinical Cancer Research"], "published-print": {"date-parts": [[2013, 11, 1]]}, "DOI": "10.1158/1078-0432.ccr-12-3629", "type": "journal-article", "created": {"date-parts": [[2013, 7, 30]], "date-time": "2013-07-30T01:43:20Z", "timestamp": 1375148600000}, "page": "5835-5841", "source": "Crossref", "is-referenced-by-count": 44, "title": ["Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer"], "prefix": "10.1158", "volume": "19", "author": [{"given": "B.", "family": "Li", "sequence": "first", "affiliation": []}, {"given": "M. C.", "family": "Simon", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2013, 7, 29]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-12-3629", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T04:26:15Z", "timestamp": 1482467175000}, "score": 21.634264, "issued": {"date-parts": [[2013, 7, 29]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2013, 10, 31]]}, "published-print": {"date-parts": [[2013, 11, 1]]}, "issue": "21"}, "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-12-3629", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T21:30:14Z", "timestamp": 1574717414366}, "reference-count": 0, "publisher": "American Association for the Advancement of Science (AAAS)", "issue": "6248", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Science"], "published-print": {"date-parts": [[2015, 8, 7]]}, "DOI": "10.1126/science.349.6248.656-c", "type": "journal-article", "created": {"date-parts": [[2015, 8, 6]], "date-time": "2015-08-06T19:00:13Z", "timestamp": 1438887613000}, "page": "656-656", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Part 4: Targeting Cancer Pathways: The Epigenetics Question"], "prefix": "10.1126", "volume": "349", "author": [{"given": "S. B.", "family": "Baylin", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Roberts", "sequence": "additional", "affiliation": []}, {"given": "A.", "family": "Shilatifard", "sequence": "additional", "affiliation": []}], "member": "221", "published-online": {"date-parts": [[2015, 8, 6]]}, "container-title": ["Science"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1126/science.349.6248.656-c", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2016, 12, 23]], "date-time": "2016-12-23T16:39:16Z", "timestamp": 1482511156000}, "score": 21.57214, "issued": {"date-parts": [[2015, 8, 6]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2015, 8, 6]]}, "published-print": {"date-parts": [[2015, 8, 7]]}, "issue": "6248"}, "URL": "http://dx.doi.org/10.1126/science.349.6248.656-c", "ISSN": ["0036-8075", "1095-9203"], "issn-type": [{"value": "0036-8075", "type": "print"}, {"value": "1095-9203", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 26]], "date-time": "2019-11-26T20:43:24Z", "timestamp": 1574801004763}, "reference-count": 0, "publisher": "American Association for Cancer Research (AACR)", "issue": "14", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Clin Cancer Res"], "published-print": {"date-parts": [[2016, 7, 15]]}, "DOI": "10.1158/1078-0432.ccr-15-2428", "type": "journal-article", "created": {"date-parts": [[2016, 5, 23]], "date-time": "2016-05-23T04:21:40Z", "timestamp": 1463977300000}, "page": "3425-3431", "source": "Crossref", "is-referenced-by-count": 65, "title": ["Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy"], "prefix": "10.1158", "volume": "22", "author": [{"given": "Elodie", "family": "Picarda", "sequence": "first", "affiliation": []}, {"given": "Kim C.", "family": "Ohaegbulam", "sequence": "additional", "affiliation": []}, {"given": "Xingxing", "family": "Zang", "sequence": "additional", "affiliation": []}], "member": "1086", "published-online": {"date-parts": [[2016, 5, 20]]}, "container-title": ["Clinical Cancer Research"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1158/1078-0432.CCR-15-2428", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T01:35:45Z", "timestamp": 1553650545000}, "score": 21.312664, "issued": {"date-parts": [[2016, 5, 20]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[2016, 7, 14]]}, "published-print": {"date-parts": [[2016, 7, 15]]}, "issue": "14"}, "alternative-id": ["10.1158/1078-0432.CCR-15-2428"], "URL": "http://dx.doi.org/10.1158/1078-0432.ccr-15-2428", "ISSN": ["1078-0432", "1557-3265"], "issn-type": [{"value": "1078-0432", "type": "print"}, {"value": "1557-3265", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T19:36:16Z", "timestamp": 1575488176128}, "reference-count": 0, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 7, 1]], "date-time": "2019-07-01T00:00:00Z", "timestamp": 1561939200000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Nuclear Medicine and Biology"], "published-print": {"date-parts": [[2019, 7]]}, "DOI": "10.1016/s0969-8051(19)30310-5", "type": "journal-article", "created": {"date-parts": [[2019, 7, 30]], "date-time": "2019-07-30T22:23:55Z", "timestamp": 1564525435000}, "page": "S44", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Indium(III) complex with a bifunctional agent for dual targeting of cancer cells"], "prefix": "10.1016", "volume": "72-73", "author": [{"given": "F.", "family": "Vultos", "sequence": "first", "affiliation": []}, {"given": "C.", "family": "Fernandes", "sequence": "additional", "affiliation": []}, {"given": "F.", "family": "Mendes", "sequence": "additional", "affiliation": []}, {"given": "J.D.G.", "family": "Correia", "sequence": "additional", "affiliation": []}, {"given": "L.", "family": "Gano", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Nuclear Medicine and Biology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0969805119303105?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0969805119303105?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 7]], "date-time": "2019-09-07T10:16:15Z", "timestamp": 1567851375000}, "score": 21.1188, "issued": {"date-parts": [[2019, 7]]}, "references-count": 0, "alternative-id": ["S0969805119303105"], "URL": "http://dx.doi.org/10.1016/s0969-8051(19)30310-5", "ISSN": ["0969-8051"], "issn-type": [{"value": "0969-8051", "type": "print"}], "subject": ["Molecular Medicine", "Cancer Research", "Radiology Nuclear Medicine and imaging"]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}